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Abstract  
During limb immobilization and bed rest, there is a significant loss of muscle mass and 
strength, and an onset of insulin resistance (IR). Subcellular localization of intramyocellular 
lipids (IMCL) is suggested to regulate the metabolic role of IMCL within skeletal muscle. IMCL 
stored in the subsarcolemmal (SS) region of the muscle fibre is associated with IR. Total IMCL 
content is unchanged by immobilization, but endurance training has been found to redistribute 
IMCL from the SS to the intermyofibrillar (IMF) region. Disuse also decreases mitochondrial 
content and function and can contribute to IR. The aim of the research presented in this thesis 
was to determine the effects of disuse on IMCL storage location and apposition with 
mitochondria and whether these changes are related to disuse-induced defects in insulin 
signalling. We also determined whether omega-3 fatty acid (FA) supplementation alters the 
effect of disuse on these outcomes. Young, healthy (n=20) women received omega-3 FA 
supplement (2.97g of EPA and 2.03g of DHA) or a placebo (isoenergetic and volume equivalent 
of sunflower oil) for 4-weeks prior to and continuing through 2-weeks of leg immobilization and 
2-weeks of recovery. Skeletal muscle biopsies were taken prior to supplementation, pre- and 
post-immobilization, and after recovery. Electron microscopy was used to determine IMCL size, 
number, area density, and subcellular localization, as well as mitochondrial area density and 
subcellular localization. Western blotting was used to examine proteins related to insulin 
signalling, IMCL metabolism, mitochondrial dynamics, and apoptosis-related signalling. There 
was no effect of omega-3 FA on any measured parameter. IMCL area density decreased in the 
SS region during immobilization and recovery due to reduced IMCL size. Central IMF IMCL 
area density increased with immobilization and returned to baseline during recovery. There was a 
corresponding decrease in mitochondrial content in the SS region during immobilization and in 
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both the SS region and central IMF during recovery. There was no effect of immobilization or 
recovery on IMCL or mitochondrial characteristics in the peripheral IMF region. PLIN5 and 
phosphorylated and total AKT content increased during immobilization and remained elevated in 
recovery. Accumulation of IMCL in the central IMF region is associated with decreased insulin 
sensitivity (IS). Previous work has found no relationship between SS IMCL content and IR in 
women, which is supported by the findings of the current study where SS IMCL area density 
decreased with immobilization. Surprisingly, there was no loss of insulin signalling protein 
content during immobilization. The differential effects induced by immobilization on insulin 
signalling in women may be mediated by estrogen and requires further examination. 
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1.0 Literature Review 
1.1 Brief introduction 
Intramyocellular lipids (IMCL) are elevated in obesity and type 2 diabetes and are related 
to insulin resistance (IR); however, IMCL are also elevated in athletes who are insulin sensitive1. 
The physiological difference between the IMCL stored in trained versus insulin resistant muscle 
is unknown, but recent investigations suggest that it is not IMCL per se, but IMCL storage 
location that are related to IR2. Therefore, how and where IMCL are stored within skeletal 
muscle may be a better indicator of the physiological/pathological role of IMCL. Endurance 
training improves insulin sensitivity (IS) and fat oxidative capacity and induces a redistribution 
of IMCL from the subsarcolemmal (SS) to the intermyofibrillar (IMF) region of the muscle 
fibre2,3. Higher IMCL stored within the SS region of the muscle fibre is related to IR2,4, thus a 
shift in IMCL storage from the SS to the IMF region may represent a shift towards available fuel 
to support exercising muscle metabolism. Muscle disuse is the antithesis of endurance training 
and induces IR in young, healthy individuals5,6. Short-term muscle disuse does not influence 
total IMCL content7, yet currently there has been no investigation into how disuse influences 
subcellular localization of IMCL and whether this may contribute to IR. Disuse also decreases 
mitochondrial content and function, which can also contribute to IR7–10. Omega-3 fatty acids 
(FA) have been shown to attenuate the loss of muscle mass during immobilization11–13, mainly 
due to its effects on muscle protein synthesis12,13, but also perhaps due to its effect on 
maintaining insulin signalling11. Therefore, the purpose of this thesis was to examine how disuse 
and omega-3 FA supplementation influences IMCL and mitochondrial characteristics and its 
relationship to insulin signalling.  
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1.2 Intramyocellular lipids 
1.2.1 Intramyocellular lipid synthesis and breakdown 
 
 Fat is stored in skeletal muscle in lipid droplets as IMCL. Typically, the lipids are stored 
in the droplet in a neutral form as intramuscular triacylglycerides (IMTG) that can be hydrolyzed 
to release free FA for oxidation as a fuel source or to act as a secondary messengers within the 
cell14,15. IMTG are composed of three fatty acyl CoA attached to a glycerol backbone. The 
glycerol backbone originates from glyercol-3-phosphate from glycolysis and is esterified with 2 
fatty acyl CoA to produce phosphatidic acid; both esterifications are catalyzed by glycerol-3-
phosphate acyltransferase (GPAT)16. The phosphate group gets removed to make a 
diacylglycerol (DAG) onto which a third fatty acyl CoA is esterified by diacylglycerol 
acyltransferase (DGAT), as seen in Figure 116. These lipids are then stored in lipid droplets, 
which consists of a monolayer of phospholipids that encapsulate the lipids within the droplet15. 
The primary isoforms of GPAT and DGAT in skeletal muscle are located on the endoplasmic 
reticulum where lipid droplets are believed to be first formed14. However, little is understood as 
to how they expand once established14.  
 For these FAs to be used as an energy source, the FAs of IMTG must be removed from 
the glycerol backbone in order to enter the mitochondria for β oxidation, as outlined in Figure 
117. Adipose triglyceride lipase (ATGL) preferentially removes the first FA from an IMTG 
molecule to form a DAG molecule. Hormone sensitive lipase (HSL) preferentially removes the 
second FA to form a monoacylglycerol molecule. Finally, monoacylglycerol lipase preferentially 
removes the final FA to release a free FA and a glycerol molecule17. From here, the fatty acyl 
CoAs are able to be transported into the mitochondria for oxidation17. 
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Figure 1: IMTG synthesis and degradation and the co-localization of PLIN5 on lipid droplets and 
mitochondria adapted from Watt et al17. DHAP: dihydroxyacetone phosphate. G3P: glycerol-3-
phosphate. GPAT: glycerol-3-phosphate acyltransferase. DAG: Diacylglycerol. SR: 
sarcoplasmic reticulum. DGAT: diacylglycerol acyltransferase. IMTG: intramuscular 
triacylglycerol. ATGL: adipose triacylglycerol lipase. HSL: hormone sensitive lipase. LD: lipid 
droplet. MAGL: Monoacylglycerol lipase. G: glycerol. FA: fatty acyl CoA. PLIN5: perilipin 5. 
Mito: mitochondria.  
 
1.2.2 Perilipin proteins 
 Originally, lipid droplets were believed to be stagnant storage facilities, but it is now 
known that they are highly metabolically active18. Amongst the monolayer of phospholipids are a 
family of proteins called perilipins that help dictate the metabolism of the lipid droplets19,20. 
There are three isoforms within skeletal muscle, all of which have been colocalized to lipid 
droplets: perilipin 2 (PLIN2), perilipin 3 (PLIN3), and perilipin 5 (PLIN5)20,21. PLIN2 and 
PLIN3 are ubiquitously expressed while PLIN5 is found in oxidative tissue21. All three proteins 
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have been shown to co-immunoprecipitate with ATGL and HSL and through these interactions 
mediate the metabolism of the lipid droplets22. 
PLIN2 overexpression increases IMCL content and favours a lipogenic gene 
expression23. It plays an important role in facilitating the storage of lipids in lipid droplets, 
specifically IMTGs20. Concurrently, PLIN2 decreases the association of ATGL with lipid 
droplets thus resulting in an accumulation of IMTGs24. Null PLIN2 mice have fewer, but larger 
lipid droplets and higher lipolysis20,25. This suggests that PLIN2 influences the stability of the 
lipid droplet while also acting as a regulator of their metabolism20.  
PLIN3 is the least studied of the PLIN proteins and therefore the least understood26. 
PLIN3 is commonly associated with smaller lipid droplets, but has been implicated in promoting 
lipolysis27,28. This is supported by its interaction with ATGL and HSL and its presence on the 
mitochondria22,29. In overfed mice, PLIN3 content dropped along with a decrease in smaller lipid 
droplets and an increase in larger lipid droplets30.  
In accordance with its anatomical location, PLIN5 is believed to play an important role in 
mediating lipolysis and oxidative control of lipid droplets31. PLIN5 localizes on both 
mitochondria and lipid droplets and its protein content has been highly correlated to oxidative 
phosphorylation protein content32,33. Using electron microscopy, PLIN5 has been found at the 
interface between lipid droplets and mitochondria, as seen in Figure 132. Conversely, PLIN5 
overexpression in the skeletal muscle of rats increases IMCL accumulation and lipid droplet size 
while promoting lipid droplet-mitochondria interaction32. This could be because under basal 
conditions, PLIN5 inhibits ATGL, but upon protein kinase A stimulation, such as that from 
exercise, PLIN5 stimulates lipolysis33,34. PLIN5 overexpression also increases the rate of fat 
oxidation in rats without changing mitochondria density, presumably due to an increase in the 
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efficiency of lipid transport rather than increasing oxidative capacity23,32. It has been suggested 
that PLIN5 couples IMTG degradation to oxidation by colocalizing IMCL to the 
mitochondria32,33. Overall, PLIN2 favours a lipogenic environment, PLIN3 favours a lipolytic 
environment, and PLIN5 can favour either scenario. 
 
1.2.3 Factors influencing intramyocellular lipid and mitochondrial content and storage 
characteristics  
1.2.3.1 Subcellular localization of intramyocellular lipids 
There are two areas within the myofibre in which IMCL are located: the SS region and 
the IMF region. The SS region is located beneath the sarcolemma; it contains typical components 
of the cell, such as the nucleus, sarcoplasmic reticulum, and mitochondria, and is the primary 
location of signal transduction within the cell35. The IMF region of a myofibre contains the 
contractile proteins of the sarcomere from which contractile force is generated. Lipid droplets in 
the SS region are more commonly shown to have detrimental effects on IS2,4,35 while lipid 
droplets in the IMF region are more often positively associated with IS36. However, the 
association between SS IMCL storage and IR has only been observed in men2,4, not women3.  
 
1.2.3.2 Fibre type differences in intramyocellular lipid storage 
The subcellular localization and total myocyte content of IMCL can be influenced by the 
fibre type of individual myofibres as their oxidative capacity greatly influences their preferential 
fuel source and thus the storage amount and localization of IMCL36. There are three types of 
muscle fibres in humans: type I, which has the highest oxidative capacity; type IIA, which more 
heavily relies on glycolytic fuel; and type IIX, which has the highest glycolytic power37. Type I 
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fibres are more highly recruited during aerobic activity while type II fibres are more highly 
recruited during anaerobic activity in agreement with their predominant fuel source. Type I fibres 
have a higher number of IMCL in either subcellular compartment than type II fibres36. The lipid 
droplet size in the SS region of type II fibres are 20% larger than those seen in type I fibres, 
potentially corresponding to a reduced oxidative capacity36. The content of IMCL is 1.5-fold 
higher in the IMF region of type I fibres than type II fibres in healthy, untrained men with no 
significant difference in the SS IMCL content, potentially corresponding to the higher reliance 
on fat metabolism in type I fibres36. Storage of larger IMCL in the SS region of type II muscle 
fibres has been associated with IR4.  
 
1.2.3.3 Effect of sex on intramyocellular lipid storage and mitochondrial content  
 
IMCL storage characteristics and accumulation are influenced by sex38–40. Women have a 
higher area density of IMCL within their skeletal muscle than men, which is due to a higher 
number of IMCL, not because their IMCL are larger40,41. Women are also better protected 
against lipid infusion-induced insulin resistance than men42, suggesting that women are better 
able to appropriately deal with increased lipid exposure. A potential mechanism by which 
women are better able to deal with increased lipid exposure is due to the fact that women have a 
greater capacity to oxidize lipids as evidenced by greater fat utilization during exercise41,43, as 
well as, greater expression/protein content/activity of enzymes related to muscle fatty acid 
uptake, IMCL synthesis and breakdown, fatty acid entry into the mitochondria and beta-
oxidation41,44. Furthermore, an acute bout of endurance exercise increases IMCL-mitochondria 
apposition in women, but not men40, which is suggestive of a greater linkage between IMCL 
breakdown and fatty acid oxidation; however, women are not seen to rely more heavily on IMCL 
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during endurance exercise40. Given the difference in IMCL storage characteristics between the 
sexes and the difference in fat metabolism between the sexes, it is important to include women in 
trials as their response to various stimuli may differ from that of men. 
 
1.2.3.4 Effect of age on intramyocellular lipid storage and mitochondrial content 
 
 Age also influences IMCL content with older individuals having a higher IMCL content 
than young38,39. The increase in IMCL content that occurs with age occurs at the same time as the 
development of IR and type II diabetes (T2D)38. Both older men and women have larger lipid 
droplets in the SS region than their younger counterparts38, but women have a higher number of 
IMCL in their SS region than men in both young and old population38. Older women also have 
more IMCL touching mitochondria than older men, though this difference between the sexes was 
not seen in the younger population38,40.  Younger individuals have a higher number and area 
density of mitochondria in both the SS region and the entire muscle fibre compared to older 
individuals, but there is no effect of age on mitochondrial size38. The higher number and 
increased apposition of IMCL to mitochondria in older women suggests that their IMCL are 
organized more favourably metabolically than older men. Older women are at a lower risk than 
older men for T2D45 and IMCL accumulation has been linked to IR1,46, as such perhaps the 
favourable storage characteristics of IMCL by older women contributes to their protection from 
T2D compared to older men.  
  
1.2.3.5 Effect of obesity and type 2 diabetes on intramyocellular storage characteristics and 
mitochondrial content 
 
 IMCL accumulation is negatively associated with IR1,2. Obese individuals and those with 
T2D, both of which are conditions characterized by IR, have a higher IMCL content than lean 
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individuals1,4,47. T2D have more IMCL stored within skeletal muscle compared to lean 
individuals, regardless of the fibre type, which is due to the increased size of their IMCL4. 
Furthermore, T2D preferentially store their IMCL in the SS region of their muscle fibres as 
compared to lean, insulin sensitive individuals4. Obese individuals and T2D also have smaller 
mitochondria and reduced mitochondrial content48, indicative of a lower oxidative capacity. 
Therefore, there are distinct IMCL and mitochondrial characteristics commonly associated with 
the IR state. 
 
1.2.3.6 Effect of endurance training and sex on IMCL storage characteristics 
 Endurance training changes IMCL storage characteristics in a sex-dependent manner. 
Endurance training reduces IMCL area density in SS region by reducing IMCL size and number 
in men2 and by reducing IMCL number in women3. The decrease in SS IMCL is positively 
correlated to improved IS in men2, but no such relationship is found in women3. As SS IMCL 
decreases, there is a concomitant increase in IMCL area density in the IMF region in both men 
and women. For men, the increase in IMCL is due to an increase in IMCL number2, while in 
women there is an increase in IMCL size3. Therefore, endurance training redistributes IMCL in 
both men and women from the SS to the IMF region, yet the morphological changes in IMCL 
induced by endurance training differ between the sexes. As such, these findings suggest there are 
sex specific differences in IMCL regulation. 
Endurance training also increases mitochondria populations, which allows for greater fat 
oxidation2,3,35,41. The increased capacity for fat oxidation with endurance training corresponds 
with the increase in mitochondria size and area density, with both increases being greater in the 
IMF than the SS region2,3,35,41. Endurance training also increases IMCL-mitochondrial 
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apposition, which corresponds with the increased β-oxidation capacity induced by endurance 
training2,3,41. The increases in mitochondrial content, function and apposition with mitochondria 
induced by endurance training are not different between the sexes41, however, IMCL-
mitochondrial apposition is increased in women, but not men following an acute bout of  
exercise40. IMCL-mitochondrial apposition is thought to be mediated by PLIN532,33. Endurance 
training has been found to increase PLIN5 content in both men and women, however, PLIN5 is 
higher in women than men31. These findings are further indicative of a greater capacity for 
women to oxidize lipid.  
 
1.2.4 Intramyocellular lipid characteristics in relation to insulin resistance 
 
1.2.4.1 Athlete’s paradox 
 
The responsiveness of skeletal muscle to insulin is a measure of skeletal muscle health. 
Ectopic accumulation of IMCL in skeletal muscle has been positively correlated to IR18,49. IMCL 
content is elevated in individuals who are obese or are T2D and the increased IMCL content is 
related to the extent of IR15. However, endurance athletes also have high concentrations of IMCL 
while exhibiting high sensitivity to insulin1. The term ‘athlete’s paradox’ is used to describe the 
similarly high concentrations of IMCL found in athletes and obese/T2D, despite disparate levels 
of IS1. IMCL levels in endurance athletes are similar to those seen in T2D, which is 2-fold higher 
than the levels in lean, sedentary individuals1. Removing endurance athletes from the evaluation, 
there is an inverse relationship between IMCL content and IS for lean, obese, and T2D 
individuals1. Thus, there must be differences in how IMCL is stored within the myocyte in an 
athlete as compared to that stored in an obese/T2D individual. In fact, while endurance athletes 
and T2D have a similar volume of IMCL in the IMF region, T2D have a 3-fold greater IMCL 
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area density in the SS region as compared with endurance athletes35. Furthermore, trained 
athletes predominantly store their IMCL in small lipid droplets in the IMF region of type I fibres, 
while T2Ds predominantly store their IMCL in large lipid droplets in the SS region of type II 
fibres4, as seen in Figure 2. With training, IMCL populations in T2D begin to develop lipid 
distribution patterns seen in athletes4. Furthermore, endurance training in lean and obese men can 
induce a shift in IMCL storage away from the SS and into the IMF region, which corresponds to 
an improvement in IS2. Therefore, it appears as though the relationship between IMCL and IS is 
influenced by the size, number, and location of IMCL within skeletal muscle and these 
characteristics can be modified by exercise to promote IS1,18. 
 
 
Figure 2: IMCL characteristics and distribution in skeletal muscle of an endurance athlete and an 
individual with type II diabetes. Black circles represent mitochondria. Yellow circles represent 
IMCL. Vertical black lines represent Z lines. The horizontal black lines separate the parts of the 
cell. Mito: mitochondria. IMCL: intramyocellular lipid. SS: subsarcolemmal region. IMF: 
intermyofibrillar region.  
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1.2.4.2 Relationship between intramyocellular lipid size and intermyofibrillar storage location 
and insulin resistance 
 
As discussed above, storage of IMCL in the IMF region appears to represent a site of 
readily available fuel for muscle metabolic needs. However, not all IMF IMCL are created equal 
as the number and size of lipid droplets within the IMF vary between individuals. A prospective 
study that evaluated the effect of IMCL accumulation during overfeeding on IR found that 
individuals who maintained more, smaller lipid droplets in the peripheral IMF region of the 
myocyte maintained greater IS than those who stored larger lipid droplets, suggesting that lipid 
droplet size and location, not overall IMCL content, play an important role in the development of 
IR30. Smaller lipid droplets have a higher surface area to volume ratio that is believed to be 
advantageous for higher FA oxidation36. Furthermore, large lipid droplets have impaired 
lipolysis50. The overfeeding protocol led to a significant reduction in the content of smaller sized 
lipid droplets around the periphery of the myocyte with a trend towards a reduction in the whole 
fibre (p = 0.07) and central IMF (p = 0.09) in young, healthy males30. Higher baseline physical 
activity protected against a loss of small peripherally located lipid droplets and smaller, 
peripherally located lipid droplets are also associated with higher whole body lipid oxidation30. 
Furthermore, highly trained endurance athletes have significantly higher IMCL content near the 
periphery of the myocyte compared to T2D, and weight matched sedentary individuals, though 
only in type I fibres51. Unfortunately, these trials did not use methods that were sensitive enough 
to differentiate between the peripheral IMF and the SS region of the myocyte 
(immunohistochemistry; oil red O staining)30,51. The peripheral IMF has the highest 
mitochondrial content and mitochondrial content increases with exercise, even in a T2D 
population35. Taken together with the positive association between IS and IMCL content in the 
IMF periphery, these finding suggest that peripheral IMF IMCL may be the least related to IR4. 
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These findings agree with the IMCL distribution seen in athletes compared to obese individuals4. 
The higher mitochondrial content in the periphery of the myocyte is supportive of the hypothesis 
that peripheral IMCL are stored as readily available fuel to support energy needs and are not 
related to IR, whereas central IMCL are a site of storage during lipid oversupply and are related 
to IR4. 
 
1.2.4.3 Muscle fibre type storage of intramyocellular lipids is related to insulin resistance 
 
IMCL area density, size, and number have all been negatively correlated with IS in the 
SS region in type II fibres, while in type I fibres only lipid droplet size is correlated negatively 
with IS4, indicating that subcellular localization is necessary when evaluating IMCL 
characteristics between fibre types. Similarly, only IMCL area density and number, but not size, 
has been positively correlated to IS in the IMF region of type I fibres4. Together, the higher 
number and smaller size of the lipid droplets in type I compared to type II fibres may be 
indicative of its higher FA oxidative capacity36 and may represent the optimal form of storing 
IMCL for oxidative purposes. The mechanistic link between IMCL stored in the SS and central 
IMF region and insulin resistance remains elusive, but may be related to the composition of the 
lipid and/or an influence of the lipids on muscle signalling pathways1,52,53.  
 
1.2.4.4 Influence of lipid intermediates on insulin sensitivity 
As detailed above, endurance athletes and obese individuals have similar concentrations 
of IMCL in their skeletal muscle1. However, obese individuals and endurance athletes do not 
have the same lipid species in their muscles. Obese individuals have more DAG and ceramides 
than athletes, which have been shown to blunt insulin signalling52–54.  
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DAG can attenuate insulin signalling by activating protein kinase C  θ, which in turn 
phosphorylates insulin substrate receptor 1 (IRS1) at Ser 307, which prevents its interaction with 
the insulin receptor and blunts its downstream signalling pathway, as seen in Figure 352,53,55. 
Despite this known association of DAG and IR, endurance athletes have double the DAG content 
as obese individuals and 50% more than lean individuals56. Similar to IMCL, subcellular 
localization is believed to influence DAG metabolism57,58. There is a significant inverse 
relationship between the percentage of total DAG localized to the membrane and IS while 
cytosolic DAG has no relationship to IS57. Di-saturated membrane DAG is also negatively 
associated with IR and is present in endurance athletes at lower concentrations than lean 
individuals, possibly because athletes have a higher protein concentration of stearoyl desaturase 
156,57,59.  Membrane DAG is also related to protein kinase C θ activation while cytosolic DAG is 
inversely related to protein kinase C θ activation, suggesting the compartmentalization of DAG 
species affects its regulation53,57. Recent data has affirmed the need to evaluate DAG subcellular 
localization rather than total content to truly elucidate its relationship with IR60.  
Another prominent lipid intermediate with negative implications on IS is ceramide52,53. 
Ceramide content is higher in obese and IR individuals compared to sedentary or endurance 
athletes46,56. It can alter the signalling cascade for phosphatidylinositol-3-kinase (PI3K) by 
preventing the translocation and recruitment of protein kinase B (AKT) to the membrane, as seen 
in Figure 354. Ceramide content is lower in endurance trained athletes56 and decreases with 
exercise46,61,62.  
Athletes also have a higher IMTG fractional synthesis rate58,59, which is suggested to 
protect against FA-induced lipotoxicity63.  IMTG fractional synthesis has been positively related 
to IS and has an inverse relationship with specific, IR-related DAG and ceramide species58,59. 
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Exercise can increase IMTG synthesis rates across several populations, including obese, T2D, 
and endurance athletes58. Exercise can also lead to a reduction in total DAG and ceramide 
content46, as well as a shift in subcellular DAG populations that has been positively correlated 
with IS58. 
 
 
Figure 3: The insulin signalling pathway to induce GLUT4 translocation to the membrane and 
the locations at which lipid intermediates inhibit this adapted from Ritter et al64. Black arrows 
mean activation. Black lines mean inhibition. Red lines mean lipid intermediate inhibition. 
Dotted lines mean translocation. Dashed lines means source of the molecule. SM: Sarcolemmal 
membrane DAG: diacylglycerol. PKC: Protein kinase C θ. LD: Lipid droplet. IRS-1: insulin 
receptor substrate 1. IR: insulin receptor. PI3K: Phosphoinositol 3-kinase. PIP2: 
phosphatidylinositol 4,5-bisphosphate. PIP3: phosphatidylinositol 3,4,5-triphosphate. Akt: 
protein kinase B. AS160: Akt substrate 160. Glut4: glucose transporter 4. 
 
1.2.4.5 Influence of perilipin proteins on insulin signalling	 
Perilipin proteins mediate the metabolism of lipid droplets, which can influence the 
accumulation or removal of lipid intermediates. PLINs also influence IS and can be influenced 
by exercise. As detailed earlier, PLIN2, PLIN3, and PLIN5 have all been shown to influence the 
metabolism of IMCL, yet different PLINs have opposing actions on IS. PLIN2 has been shown 
to both increase and decrease IS20,25,65. PLIN2 overexpression in rats leads to an increase in 
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IMTG content in skeletal muscle, but no change in DAG content, while improving IS20. Several 
other studies in mice have shown both positive65 and negative25 effects on IS when PLIN2 was 
knocked down in hepatocytes. Due to the ubiquitous nature of PLIN2, its deletion has been 
shown to lead to adaption in other PLINs, which influences its perceived impact on IS66. One 
study removed the compensatory PLIN3 upregulation that occurs when PLIN2 is knocked out 
and found IS was hindered25, while another study allowed the compensatory PLIN3 upregulation 
and found that IS improved65. Meanwhile, in a recent human study, 8-weeks of overfeeding in 
healthy, young men decreased PLIN3 content and tended to decrease IS. This was accompanied 
by no change in PLIN2 content and a reduction in small lipid droplets30, suggesting that PLIN3 
positively impacts IS while the relationship between PLIN2 and IS remains unclear.  
 As PLIN5 can either inhibit or promote lipolysis, its influence on IS is also of interest. 
After a 60 hr fast in normoglycemic young men, PLIN5 redistributed from the cytosol to the 
lipid droplet surface67. This was accompanied by an increase in lipid droplet size and number, 
both of which occurred exclusively in lipid droplets coated with PLIN5. Furthermore, the 
participants who had the greatest increase in IMCL area density had the smallest reduction in 
IS67. Increased IMCL area density also correlated with blunted fasting-induced IR and 
mitochondria dysfunction, which may indicate a role for PLIN5 in mediating lipotoxicity67. 
Overall, while the role of the PLINs in regulating IS remains unresolved, it appears as though 
PLIN2 may improve IS by sequestering lipid intermediates, PLIN3 may enhance IS, and PLIN5,  
which favours lipolysis but can permit lipogenesis, may increase IS by sequestering IMCL at rest 
and promoting IMCL lipolysis during exercise. 
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1.3 Skeletal muscle disuse 
 There are various circumstances in an individual’s life that may result in limb 
immobilization or bed rest, such as an injury, surgery, or prolonged illness. During these 
situations, there is a significant if not total elimination of movement, which induces unfavourable 
molecular and metabolic changes within skeletal muscle including the loss of muscle mass, lipid 
accumulation, mitochondrial dysfunction, and the onset of IR6,8–10,68,69. Skeletal muscle disuse is 
the antithesis to endurance training and therefore induces opposite effects on skeletal muscle as 
endurance training. 
 
1.3.1 Insulin resistance during skeletal muscle disuse 
In an insulin sensitive cell, insulin binds to the insulin receptor on the sarcolemma, 
initiating its tyrosine kinase activity to phosphorylate itself and its substrate, IRS153. From here, 
IRS1 phosphorylates PI3K, from which a cascade of protein activations and deactivations results 
in numerous, varied effects within the muscle53. One such pathway leads to the phosphorylation 
and deactivation of AKT substrate 160 (AS160) by AKT, whose inactivation allows for the 
translocation of glucose transporter 4 (GLUT4) to the sarcolemmal membrane to bring glucose 
into the cell, as seen in Figure 353. AS160 can also be phosphorylated by 5’ adenosine 
monophosphate-activated protein kinase (AMPK) to promote GLUT4 translocation70. To further 
promote glucose uptake and utilization, AMPK  phosphorylates, thereby inactivating, acetyl CoA 
carboxylase (ACC), which when active promotes FA synthesis70. As such, endurance training 
increases GLUT4 content and translocation to the membrane during and in the hours following 
exercise in skeletal muscle71. Endurance training also acutely increases the phosphorylation of 
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AS160, in accordance with the increased GLUT4 translocation72,73.  However, interference in the 
signalling cascade can result in IR.  
Skeletal muscle is responsible for 85% of glucose disposal within the body74. Limb 
immobilization, bed rest, and reduced step counts have been shown to reduce whole body IS, 
regardless of the mobility of the rest of the body6,9,69,75. IR has been positively correlated with 
reduced muscle mass and strength76,77, yet changes in IS precede changes in body composition5 
such that the 3% loss of lean muscle mass seen after one week of bed rest cannot fully explain 
the 30% reduction in whole body IS7. In fact, a reduction in step count by ~80% can reduce 
whole body IS by 20% in 7 days6,78,79. This emphasizes the need for even basal activity to 
maintain IS. There are several structural and metabolic changes that occur during skeletal muscle 
disuse that invokes glucose intolerance to promote IR7,8,80,81.  
One of the primary actions of insulin on skeletal muscle is to increase glucose uptake74.  
As stated earlier, insulin induces a cascade of signalling that results in the translocation of 
GLUT4 to the sarcolemmal membrane82. A single day of inactivity can reduce glucose uptake by 
39%80 and one week of bed rest decreases whole body IS by 29%7. Bed rest leads to decreased 
GLUT4 content and therefore reduced glucose uptake and glycogen formation, as seen in Figure 
4A83–85. Two weeks of immobilization has also been shown to reduce hexokinase content85, AKT 
content, the upstream regulator of GLUT4 translocation85, and reduce the activity of glycogen 
synthase10,85,86. Hexokinase converts glucose into glucose-6-phosphate, which is then converted 
to glycogen via glycogen synthase87. With a reduction in hexokinase and glycogen synthase 
activity, glucose content remains high in the cell, disrupting the concentration gradient between 
the blood and the muscle, reducing glucose uptake87. Taken together, these findings indicate that 
glucose metabolism is hindered at several steps with disuse leading to IR.  
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1.3.2 The effects of disuse on perilipin proteins 
 
PLIN2 and PLIN5 are the most abundant PLIN proteins in skeletal muscle23 and are 
therefore the most commonly studied. PLIN2 promotes the accumulation of IMCL and PLIN2 
content increases with age88,89. In an older population, there is a significant increase in PLIN2 
content with reduce mobility10,89, which has a strong positive correlation with muscle atrophy 
proteins89. Even in a young population, PLIN2 content increases with reduced mobility88, though 
this is not always seen10. These findings suggest that PLIN2 is involved in regulating the 
accumulation of ectopic lipids during disuse. Interestingly, PLIN2 content increases 3-fold with 
endurance training in obese, but not lean women31, suggesting that adiposity may regulate 
changes in PLIN2. As PLIN2 specifically promotes the accumulation of IMTGs in lipid droplets 
and obese individuals tend to have higher concentrations of DAGs and ceramides, perhaps 
PLIN2 content increases in obese women as a mechanism by which to remove the lipid 
intermediates and may represent a potential mechanism by which endurance training increases 
IS. Therefore, PLIN2 content can increase as a result of two opposing stimuli that induce 
differential effects on IS. As higher PLIN2 content can result in both positive and negative 
effects on IS, the relationship between PLIN2 and IS is unclear and requires further 
investigation. 
 PLIN5 is commonly associated with lipolysis due to its adjacency to both IMCL and 
mitochondria31–33. Therefore, it would be expected that as disuse induces lipid 
accumulation10,86,90, PLIN5 content would decrease. However, when not stimulated by exercise, 
PLIN5 can also support IMCL accumulation32, thus during a period of disuse it is possible that 
PLIN5 could increase in order to allow for greater lipid synthesis. In young men, reduced 
mobility has no effect on PLIN5 content and in older men, PLIN5 content has been shown to 
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remain stable10 or decrease with reduced mobility10,89. Since endurance training increases IMCL-
mitochondrial apposition, it could be speculated that disuse would decrease the apposition of 
IMCL with mitochondria. Decreased IMCL-mitochondria apposition would support the reduced 
fat oxidation seen with disuse and would agree with the reduced PLIN5 content and may 
contribute to disuse-induced IR. PLIN5 overexpression has been shown to promote neutral 
IMCL accumulation in response to a high fat diet without compromising IS in rats23, which is 
supportive of a role for PLIN5 to mediate lipid-induced IR. However, despite the implications of 
PLIN5 content on IS, no relationship has been found between PLIN5 content and IS, therefore 
any benefit of PLIN5 on IS appears to be indirect91. However, the current discrepancies in the 
literature suggest that further investigation is needed to understand the effect of disuse on PLIN5 
content. 
 
1.3.3 The effect of disuse on intramyocellular lipids 
 
The effects of disuse on total IMCL content are conflicting, perhaps due to differences in 
the length of the disuse intervention. A recent study found that one week of bed rest induces 
significant whole body IR without the accumulation of IMCL7; however, an examination of 
subcellular IMCL localization was not performed. Alternatively, during longer periods of 
immobilization ( > 2 weeks), there is an accumulation of IMCL within skeletal muscle along 
with the development of IR10,86,90, but once again no examination of the subcellular localization 
was conducted. Furthermore, no study has examined the effect of disuse on IMCL size, another 
IMCL characteristic that has been shown to be related to IR. Since endurance training can alter 
IMCL storage characteristics and higher IMCL size and storage in the SS region of the myocyte 
are associated with IR, examining total IMCL content may be missing the critical effects of 
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disuse on IMCL in relation to IR. Using electron microscopy allows for the investigation of 
changes in IMCL subcellular localization and individual lipid characteristics induced by disuse 
that precede IMCL accumulation. Using electron microscopy we may be able to determine the 
critical effects of disuse on IMCL in relation to IR.   
The accumulation of lipids seen in longer periods of disuse also suggests that there are 
increases in other lipid species10,86,90. Twenty-eight days of bed rest does not change total DAG 
content in skeletal muscle92, but 7 days of bed rest has been shown to change specific DAG and 
ceramide species7. These findings suggest, in an opposing action to exercise, disuse can induce 
changes in specific populations of lipid intermediates that could blunt insulin signalling and 
result in IR. Therefore, the insulin signalling cascade could illuminate the points of intersection 
between disuse, IR, and IMCL metabolism. 
 
1.3.4 Disuse decreases mitochondrial content and function 
 
Disuse leads to a decrease in mitochondrial content and function7–10. Mitochondrial 
content can be measured directly with electron microscopy or indirectly through biochemical 
markers that represent mitochondrial content (i.e citrate synthase (CS)). In as little as 5 days 
disuse can reduce mitochondrial content as evidenced by the reduced expression of Cs 
mRNA8,93; this is corroborated by a corresponding decrease in CS content7. These results are 
further supported by electron microscopy analyses showing a decrease in mitochondrial number, 
size, and area density with disuse94,95. The reduction in mitochondrial content of oxidative 
proteins suggests that immobilized muscle has a lower capacity for oxidative metabolism. 
Reduced mitochondrial content and function are found in T2D and contribute to the development 
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of IR82,96. Therefore, similar alterations in mitochondrial content and function induced by disuse 
may contribute to the development of disuse-induced IR. 
 
1.3.5 Decrease in mitochondrial dynamics with disuse 
 
Mitochondria are dynamic structures that constantly undergo fission and fusion to 
maintain mitochondrial health97. Mitochondrial fission is mediated by two proteins, dynamin-
related protein 1 (DRP1) and fission 1 (FIS1), whereas mitochondrial fusion is mediated by two 
different proteins, mitofusin 1/2 (MFN1/2) and optic atrophy 1 (OPA1). MFN1/2 fuse the outer 
membranes of two conjoining mitochondria and OPA1 fuses the inner membranes98,99. Fission is 
the division of one mitochondria into two smaller mitochondria. FIS1 is a receptor on the outer 
membrane of mitochondria that recruits DRP199. DRP1 surrounds the mitochondria like a band 
and constricts and separates the mitochondria into two98,99. In healthy cells, mitochondrial fusion 
is used to counteract the effect of reactive oxygen species (ROS) on mitochondrial DNA99. By 
fusing mitochondria, the presence of more mitochondrial DNA can combat gene product 
deficiencies that may limit or hinder mitochondrial function97,99. Fission can be used to remove 
dysfunctional portions of mitochondria to contain and remove the damaged mitochondria 
effectively and efficiently97. Fission is also important during cytokinesis to ensure that both cells 
have mitochondria upon division99. 
During disuse, mitochondria increase their ROS production75,100. ROS induce changes in 
mitochondria morphology via increased fission, as evidenced by increases in the expression of 
DRP1 and FIS1, as seen in Figure 4B101,102. Higher mitochondrial fission is associated with 
mitochondrial autophagy and increased muscle atrophy94,102,103. Mitochondria fission can 
upregulate forkhead box O3 (FOXO3) protein expression through AMPK, independent of AKT, 
 22 
which in turn induces the expression of genes for protein ligases104. The pro-apoptotic factor 
BCL2 associated X protein (BAX) inhibits MFN2 activity and MFN2 overexpression inhibits 
BAX expression105. Similarly, OPA1 can protect against apoptosis by preventing the release of 
cytochrome c induced by BAX106. While fission and fusion are necessary for normal 
mitochondrial function, an imbalance between the two with a preference for fission has been 
found to have negative implications on cell function104,107. However, the results are less 
definitive in a disuse environment. During hindlimb suspension, some animal studies have found 
increased fission proteins (DRP1 and FIS1) and decreased fusion protein expression 
(MFN2)104,107, while others have shown a decrease in both fusion (MFN1/2, OPA) and fission 
(DRP1 and FIS1) proteins94,108,109. In older adults, 10-days of bed rest did not change either 
fusion or fission protein content110. Therefore, the relationship between fusion and fission on 
mitochondrial function in an immobilization environment is unclear and requires further 
examination. 
 
1.3.6 The effect of disuse on apoptosis-related signalling 
Apoptosis is the programmed death of a cell. Apoptosis is commonly shown to be 
upregulated with disuse111 and one family known to help regulate apoptotic signalling is the β-
cell lymphoma family of proteins111,112. In healthy cells, apoptosis is tightly controlled. One such 
protein that helps control apoptotic signalling is β cell lymphocyte 2 (BCL2)113,114. BCL2 is an 
anti-apoptotic factor that binds the pro-apoptotic factor BAX. BAX binds itself or another 
protein BCL2 antagonist/killer 1 (BAK) to form an oligomer. BAX/BAK oligomers will create 
pores in the outer membrane of mitochondria, which releases cytochrome c into the 
cytoplasm115,116. Cytochrome c can induce caspase activity, which will degrade proteins and 
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fragment DNA, thereby causing apoptosis103,115,117. When bound to BCL2, BAX cannot 
oligomerize, which will prevent apoptosis115. The ratio of BCL2 to BAX represents the integrity 
of the outer mitochondrial membrane103,107 therefore their values are often reported as a ratio 
rather than individual content. Disuse decreases the ratio of BCL2 to BAX107,108,118 as a result of 
BCL2 decreasing and BAX increasing107,118. As BAX is an upstream regulator of apoptosis, 
lower ratio of BCL2 to BAX may represent an increase in apoptosis-related signalling and can 
contribute to the loss of muscle mass seen with disuse107. 
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Figure 4: The effect of disuse on glucose metabolism (A) and mitochondrial content and function 
(B). Black lines mean transportation. Black arrows mean activation. Dotted black lines mean 
translocation. Red block arrows mean protein content. Red arrows mean enzymatic activity. 
Dashed red arrows mean gene expression. IR: Insulin receptor. IRS1: Insulin receptor substrate 
1. Akt: Protein kinase B. Glut4: glucose transporter 4. HK: Hexokinase. G-6-P: glucose-6-
phosphate. GS: Glycogen synthase. Mito: Mitochondria. β-Ox: β-oxidation. βHAD: β-
hydroxyacyl CoA dehydrogenase. CS: Citrate synthase. TCA cycle: The citric acid cycle. COX: 
Cytochrome c oxidase proteins. ROS: Reactive oxygen species. DRP1: Dynamin-related protein 
1. Fis1: Fission 1.  
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1.4 Omega-3 fatty acids 
 Omega-3 FA are polyunsaturated FA that are characterized by their first double bond at 
the third carbon from the methyl end of their hydrocarbon tail119. Humans are unable to 
synthesize omega-3 FA so they must be obtained from the diet119. One prominent source of 
omega-3 FA in the human diet is fish, who absorb them from the plankton and algae that they 
eat119. Omega-3 FA from fish is composed of two FA: eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA). EPA and DHA have been shown to have positive impacts on the 
heart and brain, but recent studies suggest that it also positively impacts skeletal muscle by 
increasing muscle protein synthesis12,13, muscle mass120, and strength121. 
 
1.4.1 Omega-3 fatty acid supplementation impact on insulin sensitivity 
 
The influence of omega-3 FA on IS is still debated. EPA increases basal glucose uptake 
by increasing Glut1 expression in human myotubes122. A combined supplementation of EPA and 
DHA has been shown to increase Glut4 and Irs1 transcription in response to a high fat diet123; 
however, this is not always found122,124. Observational studies in humans support increased IS 
with omega-3 FA supplementation, yet several studies have failed to increase IS in T2D and 
obese individuals125. In a meta-analysis by Lalia et al. (2016), 10 out of 13 studies in non 
diabetic populations failed to improve IS across a range of omega-3 FA supplementation 
concentrations and durations ranging from 300 mg to 3.9 grams for 1 to 6 months, 
respectively125. Meanwhile in rats, omega-3 FA from fish oil normalized insulin action blunted 
by a high fat diet, which was highly correlated with the percentage of omega-3 FA in 
phospholipids126. In rats, EPA supplementation was shown to change the composition of 
phospholipids in the plasma membrane to prevent dietary-induced IR and increase glucose 
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infusion rate 3-fold127. The inconsistency between animal and human studies may be due to a 
preventative versus curative approach, respectively, and differential organismal responses to 
omega-3 FA supplementation55,125. The range of supplement duration, doses, and composition 
(EPA:DHA)nbetween human studies also makes it hard to draw comparisons125.   
 
1.4.2 Omega-3 fatty acid supplementation impact on intramyocellular lipid metabolism 
 
 Two studies involving protocols lasting 3 or 12-weeks found that omega-3 FA 
supplementation increased basal FA oxidation in young adults and older women128,129. Whole 
body resting metabolic rate was also increased, but only after 12-weeks of supplementation128,129. 
These findings suggest that perhaps IMCL content would decrease with omega-3 FA 
supplementation. This is supported by animal work which has shown that incubation of murine 
adipocyte cells with DHA can increase Atgl130. Furthermore, EPA and DHA also tend to increase 
Hsl in murine adipocytes, independently130. However, findings from a study using acute EPA 
exposure of human skeletal muscle cells suggest that EPA diverts FA to IMCL122, but the effects 
of omega-3 FA supplementation on IMCL content remains unstudied.  
Studies involving omega-3 FA supplementation have shown that EPA and DHA only 
minimally (~1%) get incorporated into IMCL in skeletal muscle; instead, EPA and DHA get 
incorporated into phospholipids or act as signalling molecules131.  In human hepatoma cells and 
murine liver cells, phosphatidylcholine (PC) has been found to be the most abundant 
phospholipid class in lipid droplet monolayers followed by phosphatidylethanolamine (PE)132,133. 
Three months of omega-3 FA supplementation in men and women increased omega-3 
incorporation into skeletal muscle phopholipids 2.5-fold131. Twelve weeks of EPA and DHA 
supplementation in men changed the profile of mitochondrial phospholipids by increasing the 
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incorporation of EPA and DHA into PC and PE species, while decreasing the presence of 
linoleic acid and arachidonic acid, two omega-6 FA134. The incorporation into phospholipids was 
accompanied by an increase in ADP sensitivity and submaximal oxidative activity134. Therefore, 
it may be possible that EPA and DHA are incorporated into the phospholipid classes also found 
in the lipid droplet monolayer and therefore alter lipid droplet protein functioning, as they do in 
the mitochondria134. With higher lipase content and activity, there is a potential for omega-3FA 
supplementation to prevent the accumulation of IMCL during disuse.  
Omega-3 FA supplementation may also influence IMCL metabolism through cell 
signalling. Omega-3 FA are potent activators of transcription factors such as the peroxisome 
proliferator-activated receptor (PPAR) family119. PPAR α and PPARγ135 control the expression 
of proteins involved in lipid metabolism136. During a high fat diet, supplementation with both 
DHA and EPA (~4:1) reduces lipogenic gene expression while increasing markers of FA 
oxidation and mitochondrial content in mice137. Supplementation also induces a significant 
increase in Dgat1, which could lead to increased protein content of DGAT1, the enzyme that 
catalyzes the addition of a free fatty acid to a DAG molecule to produce an IMTG137. Increases 
in IMTG synthesis have also been seen in human myotubes upon incubation with EPA122. While 
the relationship between DAG and disuse is unclear92,138, IMTG synthesis has been positively 
linked to IS59, so in a disuse model omega-3 FA induced upregulation of IMTG synthesis may 
prevent the accumulation of lipid intermediates and thereby positively influence IS55. Also, 
omega-3 FA supplementation reduces ceramide content in mice and improves IS123. Collectively, 
omega-3 FA supplementation could influence the phospholipid membrane of IMCL or cell 
signalling to mitigate the effects of disuse on skeletal muscle. 
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1.5 Techniques to assess intramyocellular lipid content 
 IMCL can be quantified using many different methods including biochemical techniques, 
histochemical methods, electron microscopy, and spectroscopy. Biochemical techniques 
indirectly measure IMCL content by measuring the glycerol content of a sample. Commonly, 
biochemical techniques are performed on whole muscle homogenate, which is a mix of both 
intramyocellular and extramyocellular lipid pools, therefore they often overestimate IMCL 
content139. As well, biochemical methods determine overall IMCL content, but give no 
indication as to where the IMCL are stored or their morphology, which can influence its 
relationship with IS4. 
Histochemical techniques use stains that target the neutral lipids found in the intracellular 
membranes of IMCL, which can then be visualized using fluorescence or bright field 
microscopy140. Two common stains for IMCL are Bodipy and oil red O. While both of these 
stains bind to the neutral lipids within IMCL, they also bind neutral lipids found in intracellular 
membranes140. Because the stains do not exclusively bind lipids in IMCL, it can be difficult to 
differentiate whether the fluorescent signal is from IMCL or other lipid populations within the 
cell140. One advantage of using histochemical IMCL analysis is that you can simultaneously stain 
for fibre type as well139. By staining for fibre type using myosin heavy chain antibodies, IMCL 
content, size, and localization can be determined based on fibre type. Fibre type influences 
IMCL storage and therefore provides valuable information for understanding the pathological 
and physiological storage of IMCL. However, histochemical techniques using traditional 
microscopy do not have the sensitivity to differentiate between the SS and the IMF regions, and 
these methods can only allow for determination of relative shifts of IMCL between the centre 
and periphery of the cell. 
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Electron microscopy is one of the most favourable techniques with which to analyze 
IMCL characteristics. Muscle samples are fixed in glutaraldehyde, embedded in resin from 
which very thin sections of sample are cut and stained with uranyl acetate and lead citrate to 
allow for visualization of muscle organelles and ultrastructure at very high magnifications using 
transmission electron microscopy (TEM). TEM is able to image samples with enough 
magnification and resolution to examine subcellular organelle organization and characteristics, 
including IMCL size and number, while differentiating between the SS region and the IMF 
regions. Unfortunately, TEM is not well suited to determining muscle fibre type unless immuno-
electron microscopy methods are employed. However, immuno-electron microscopy requires 
that the sample be preserved in formaldehyde rather than glutaraldehyde, which does not 
preserve the muscle ultrastructure as well and reduces the ability to visualize muscle organelles, 
particularly mitochondria141,142. However, determining muscle fibre type can be achieved by 
using correlative electron microscopy. Correlative electron microscopy integrates the 
fluorescence of light microscopy with the magnification and resolution of TEM143. The fibre type 
is determined using fluorescent labels to illuminate fibre type specific proteins and the image can 
be overlaid with a TEM image. One disadvantage to correlative microscopy is that many of the 
labels used for fluorescence are green fluorescent proteins, whose fluorescence can be muted by 
heavy metals, yet heavy metals are necessary for electron microscopy preparation144. Therefore, 
TEM is ideally suited to provide data related to IMCL morphology and location, whereas 
correlative electron microscopy is ideally suited to determine muscle fibre type. Thus, the 
researcher needs to prioritize what outcomes are of most importance when planning their 
analyses as it is difficult to determine muscle fibre type and IMCL characteristics and storage 
location using one method.  
 30 
Finally, proton magnetic resonance spectroscopy (H+ MRS) is a non-invasive way to 
measure IMCL content. H+ MRS is able to distinguish between IMCL and extramyocellular 
lipids because their morphologies produce differing resonances145. H+ MRS also has the 
sensitivity to measure the degree of unsaturation of the lipids. Unfortunately, H+ MRS is unable 
to distinguish the subcellular location of the IMCL, which is shown to have implications on 
IMCL metabolism and relate to IR4. Overall, electron microscopy is the technique best suited to 
identify changes in IMCL morphology and location in response to a stimulus. 
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2.0 Study Rationale 
The size, number, and storage location of IMCL have been shown to influence IMCL 
metabolism4. T2D, a population with IR, predominantly store their IMCL in large lipid droplets 
in the SS region of type II fibres4. Athletes, an insulin sensitive population, predominantly store 
their IMCL in small lipid droplets in the peripheral IMF region of type I fibres4. IMCL content, 
size, and number is negatively associated with IS in type II fibres while IMCL content and 
number are positively associated with IS in type I fibres4, suggesting that athletes store their 
IMCL in a metabolically favourable location while T2D do not. Endurance training redistributes 
IMCL from the SS region to the IMF region2,3. Muscle disuse is the antithesis of endurance 
training and periods of disuse have been shown to induce IR in as little as one week without the 
accumulation of IMCL7. However, longer periods of disuse have been shown to induce the 
accumulation of IMCL along with impaired glucose handling10. Therefore, there may be changes 
in the storage location of IMCL that precede IMCL accumulation that contribute to the IR seen 
during disuse. Since disuse is the opposite of endurance training, disuse may induce a 
redistribution of IMCL from the IMF to the SS region, which would have negative implications 
on IS without changing total IMCL content. To date, there has been no examination on the effect 
of immobilization of IMCL subcellular localization, which was one of the objectives of this 
study. As well, disuse has been shown to induce whole-body IR6,9,69,75. The accumulation of 
IMCL also results in accumulation of lipid intermediates that have been shown to negatively 
impact insulin signalling53,55,135. Thus, evaluation of the insulin signalling pathway may identify 
a role for IMCL accumulation in disrupting insulin signalling that thereby contributes to whole-
body IR.  
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Disuse decreases mitochondrial content and function7,8,94,95. Mitochondrial fission and 
fusion has been implicated in contributing to mitochondrial dysfunction in immobilization104,107. 
Mitochondrial fission has also been shown to increase autophagy and therefore increase muscle 
atrophy104. Similarly, mitochondrial dysfunction has been shown to increase apoptosis75,100. 
Therefore, another objective of this study was to evaluate mitochondrial storage characteristics 
and mitochondria-related signalling following a period of disuse and remobilization.   
Disuse leads to IMCL accumulation, which is believed to contribute to reduced IS. 
Omega-3 FA supplementation have been shown to increase the gene expression of proteins 
involved in fat transport, β-oxidation, and oxidative phosphorylation129,134,137. Omega-3 FA 
supplementation can also increase the gene expression of IRS1 and GLUT464. Therefore, omega-
3 FA supplementation may lower IMCL accumulation by increasing IMCL metabolism and 
potentially limit the impairments in insulin signalling seen with immobilization. 
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2.1 Objectives 
The experiment detailed in this thesis examined the physiological effects of disuse on IMCL 
and mitochondria storage characteristics and location in relation to insulin signalling. As well, it 
examined whether omega-3 FA supplementation influenced IMCL characteristics and whether 
this relates to insulin signalling.  
 
2.2 Hypotheses 
Our a priori hypotheses were that: 
1. Disuse would increase SS IMCL content due to an increase IMCL size, not number.  
2. Disuse would decrease peripheral IMF IMCL content due to a decrease in the number of 
IMCL, not size. 
3. IMCL content in the central IMF region would increase due to an increase in IMCL size, 
not number.   
4. IMCL-mitochondria apposition would decrease in both the SS and the IMF regions as a 
result of disuse.  
5. Protein content or phosphorylation status of enzymes of the insulin signalling pathway 
(IRS1, AKT, AS160, GLUT4, AMPK, ACC) would be blunted as a result of disuse.  
6. Disuse would increase PLIN2 and decrease PLIN5 content. 
7. Disuse would increase BAX and FIS1 expression and decrease OPA1 and BCL2 
expression. 
8. Omega-3 FA supplementation would mitigate the effect of disuse on IMCL storage 
location, IMCL-mitochondria apposition, mitochondrial content, insulin signalling, and 
PLIN proteins.   
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3.0 Methods 
3.1 Participants 
 
Twenty healthy, young women were recruited for this study. The trial was approved by 
the Hamilton Integrated Research Ethics Board (HIREB-1457) and met all the standards for the 
use of human participants by the Canadian Tri-Council Policy on the ethical use of human 
subjects in research146 and conformed to the standard set by the latest version of the Declaration 
of Helsinki147. Participants provided written informed consent to participate. All participants 
were between the ages of 18 to 30 y, non-smokers, and had no history of lower limb injuries 
within one year of the study that necessitated a period of disuse. Participants were excluded if 
they were taking any analgesic or anti-inflammatory drugs chronically, had a history of 
neuromuscular problems or muscle and/or bone wasting diseases, had any acute or chronic 
illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin or 
non-insulin dependent diabetes or metabolic disorders, used medications known to affect 
metabolism, or were allergic to fish. All participants completed a general health screening 
questionnaire. Oral contraception was not an exclusion, though those using oral contraceptives 
were evenly distributed between the two groups. 
 
3.2 Protocol 
Following the initial meeting for consent, participants visited the lab 4 times over an 8-
week period to complete this study, as outlined in Figure 5. On the first visit, participants 
underwent a DXA scan to determine body composition and were randomized by a computer 
generated sequence (www.randomization.com) into either the active intervention group (fish oil) 
or the control group (sunflower oil).  Each group received 20 mL doses of either omega-3 FA 
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(2.97 g EPA and 2.03 g DHA) or sunflower oil (an isoenergetic and volume equivalent), which 
they continued to take for the duration of the study. Supplementation was provided as 5 capsules 
per day (Infinit Nutrition, Windsor, ON, Canada). The sunflower oil placebo had a high oleic 
acid content (75%). Both supplements had coconut flavouring to mask the participants to their 
supplementation group. After 4-weeks of supplementation, one of their legs was randomly 
assigned to immobilization for 2-weeks using a second randomization scheme 
(www.randomization.com). Their leg was held in a brace at a 60° angle of flexion using a Donjoy 
X-ACT knee brace (DJO LLC, Vista, CA, USA). Following two weeks of immobilization, 
participants underwent two weeks of recovery where they returned to baseline activities. Skeletal 
muscle biopsies of the immobilized leg were taken from the vastus lateralis muscle before 
supplementation (pre), before immobilization (D0), after immobilization (D14), and after 
recovery (D28). Samples from the biopsy were immediately stored in 2% gluteraldehyde for 
TEM analysis or flash frozen in liquid nitrogen and stored at -80 °C for western blotting analysis.  
 
 
Figure 5: Schematic diagram of experimental design.  
 
3.3 Electron microscopy analysis 
Muscle samples were fixed in 2% glutaraldehyde for no more than 1 month before 
continuing the TEM sample preparation process. All sample preparation was done by trained 
technicians at the McMaster University Medical Centre Electron Microscopy facility. Samples 
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were post fixed in 1% osmium tetroxide, serially dehydrated with ethanol, and embedded in 
Spurr’s resin. Thin sections (90 nm) were cut using a diamond knife ultramicrotome (Leica UCT 
microtime, Wetzler, Germany) and placed on Cu grids. Samples were stained with uranyl acetate 
followed by lead citrate and coated with a thin carbon layer. Sections were viewed on a 
transmission electron microscope (Phillips CM10 TEM, Eindhoven, Netherlands) at 5800X. 
Sixteen images were taken at each time point for each participant: 8 from the IMF region, 6 from 
the SS region with a nucleus, and 2 from the SS region without a nucleus (Fig 6). A total of 720 
images were analyzed for this study.  
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Figure 6: Representative image of a TEM image. The white line separates the SS region (right) 
from the IMF region (left). The IMF is further separated by a white line into the peripheral IMF 
and central IMF regions. IMCL (light grey) and mitochondria (dark grey) are identified with a 
white arrows.  
 
 TEM images were analyzed for lipid and mitochondria storage characteristics using 
ImageJ (Version 1.51a, National Institute of Health, USA). Lipid droplets and mitochondria were 
circled and converted to actual size using a scale bar from which the mean individual IMCL size 
(µm2), number (#), and the area density (%) of IMCL were reported. Individual mitochondria 
number and size characteristics were not reported since mitochondria are a tubular network148, 
and thus a 2 dimensional image is not an appropriate method to assess mitochondrial 
size/number; however, this information was used to determine mitochondrial area density (%). 
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IMCL and mitochondrial content was reported as area density because the images are 2-
dimensional, which more accurately corresponds to the percentage of area covered by either 
IMCL or mitochondria rather than true volume. The proportion of IMCL in contact with 
mitochondria was reported as a percentage. All measures were analyzed relative to area such that 
every measure was assessed within the SS region, within the total IMF region, and within the 
IMF region when subdivided into the peripheral IMF region and the central IMF region. The 
peripheral IMF region was defined as within 3 sarcomeres from the SS region.  
 
3.4 Western blotting analysis  
Muscle samples were homogenized in ice cold 25 mM Tris buffer (25 mM Tris, 0.5% 
(v/v) Triton X-100, and protease/phosphatase inhibitor tablets (Roche Diagnostics, Laval, QC, 
Canada)) using a Tissuelyzer (Qiagen, Hilden, Germany). The samples were centrifuged at 1500 
g at 4 °C for 10 min. The supernatant was removed, flash frozen, and stored at -80°C for future 
analysis. The protein content of each sample was determined using the bicinchoninic acid assay 
technique. From here, samples were prepared in Laemmli buffer (0.5 M Tris-HCl, glycerol, 10% 
SDS, 1% bromophenol blue, β-mercaptoethanol, and ddH2O) and stored at -80 °C ready for 
western blotting analysis. 
Proteins involved in insulin signalling, mitochondrial function, and IMCL metabolism 
were assessed using SDS-PAGE and western blotting. Equal amounts of protein (10 µg) of each 
sample were run on 4 - 15% Criterion TGX Stain-Free protein gels (BioRad, Hercules, CA, 
USA) at 200 V for 45 min. A protein ladder (Precision Plus Protein Standard, BioRad, Hercules, 
CA, USA) and standard curve (pooled from all samples) were run on every gel. Proteins were 
transferred to a PVDF membrane. Total protein was determined post transfer using a Chemidoc 
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MP imaging system (BioRad, Hercules, CA, USA). The membranes were blocked in blocking 
solution (TBST buffer: 20 mM Tris base, 137 mM NaCl, and 0.1% (v/v) Tween 20, pH 7.5, with 
either 5% (w/v) non-fat dry milk or bovine serum albumin) for 2 hr. Membranes were 
immunoprobed at 4°C for 12 hr with the corresponding primary antibody, detailed in Table 1. 
Next, the proteins were immunoprobed with horse-radish peroxidase-conjugated secondary 
antibodies, detailed in Table 1. Finally, the proteins were incubated with Clarity or Clarity Max 
Western ECL Blotting substrates (BioRad, Hercules, CA, USA) before being imaged on the 
Chemidoc imaging system (BioRad, Hercules, CA, USA). Bands were quantified using 
ImageLab (Version 6.0.1, BioRad, Hercules, CA, USA) and protein content was normalized 
using total protein and the standard curve obtained from the gel. 
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Table 1: Antibodies for western blot analysis with the specifics for blocking, primary antibody, 
and secondary antibody incubations.  
Pathway of 
interest 
Protein Ab 
Provider 
Blocking 
Agent 
1° Ab 
solution 
2° Ab 
solution 
IMCL 
Metabolism 
PLIN2 Progen 
610102 
0.5% skim 
milk in 1X 
TBST 
1: 1,000 1: 10,000 
PLIN5 Progen 
GP31S 
5% skim 
milk in 1X 
TBST 
1: 1,000 1: 10,000 
Total AMPK α CS 2532S 5% skim 
milk in 1X 
TBST 
1: 1,000 1: 10,000 P-AMPK α  
(Thr 172) 
CS 2531S 
P-ACC (Ser79) CS 3661 
Insulin 
Signalling 
IRS1 CS 2382 
5% skim 
milk in 1X 
TBST 
1: 1,000 1: 10,000 
Total AKT CS 4685 
P-AKT (Ser473) CS 9271S 
Total AS160 CS 2447S 
P-AS160  
(Thr 642) 
CS 4288S 
GLUT4 Fisher 
PA1-1065 5% skim milk in 1X 
TBST 
1: 2,000 in 
5% BSA in 
0.025% 
PBST 
1: 10,000 
Mitochondrial 
Function 
BAX (N-20) SC-493 2.5% skim 
milk in 1X 
TBST 
1: 1,000 1: 5,000 
BCL2 (C-2) SC-7382 5% skim 
milk in 1X 
TBST 
1: 1,000 1: 10,000 FIS1 (C-9) SC-
376469 
OPA1 (D-10) SC-
393296 
5% BSA in 
1X TBST 1:100 1:500 
All 1° and 2° antibodies solutions were the same as the blocking solutions unless otherwise 
stated. Ab: Antibody. CS: Cell Signalling. SC: Santa Cruz. 
 
 
3.5 Statistical analyses 
 The data are presented as means ± standard error unless otherwise stated. All statistical 
analyses were performed as a two-way mixed model ANOVA with supplementation group as the 
between group factor and time as the within group factor using SPSS, version 25 (IBM Corp., 
Armonk, New York, USA). The statistical significance was defined as p < 0.05, while a trend 
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was defined as 0.05 < p < 0.1. All final images were created using GraphPad Prism (GraphPad 
Software Inc, CA, USA). 
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4.0 Results 
4.1 Participant characteristics 
 
There were no differences in baseline characteristics between groups (Table 2).  
Table 2: Participant characteristics 
20 healthy, female participants 
 Placebo Fish Oil p value 
Age (y) 22.6 ± 1 22.4 ± 1 0.900 
Height (cm) 164.6 ± 1.7 165.8 ± 2.4 0.724 
Weight (kg) 63.0 ± 2.3 63.7 ± 2.4 0.851 
BMI (kg/cm2) 23.3 ± 0.8 23.2 ± 0.7 0.930 
% BF 28.7 ± 2.1 33.0 ± 1.8 0.157 
Data are means ± SEM. BMI - body mass index, % BF - percent body fat. 
 
 
4.2 Electron microscopy analysis 
4.2.1 Pre-supplementation to pre-immobilization comparisons 
 
 Thirteen individuals had electron microscopy samples, 6 taking placebo and 7 taking fish 
oil. To evaluate the independent effect of the fish oil, all characteristics were first measured 
between the pre-supplementation and pre-immobilization time points. There was no effect of 
supplementation (main effect or interaction) on IMCL characteristics in the SS region after 4-
weeks of supplementation (Supp. Fig 1). Similarly, there was also no significant effect of 
supplementation on the IMCL characteristics in the IMF region (Supp. Fig 2). There was also no 
change in the proximity of IMCL to mitochondria in the SS or the IMF regions (Supp. Fig 3). 
Finally, there was no change in the mitochondrial area density in the SS or IMF regions (Supp. 
Fig 4). 
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4.2.2 Pre-immobilization, post immobilization, and post recovery comparisons 
 
As there was no effect of the supplementation on any measured characteristics before 
immobilization the pre-supplementation data was removed to focus on the effect of disuse. One 
individual only had pre-supplementation and pre-immobilization data so their data was excluded 
from these comparisons, making the total number of participants 12. There was no effect of 
omega-3 FA supplementation during immobilization or recovery (main effect or interaction) on 
IMCL or mitochondrial characteristics. Therefore, all data were graphed to focus on the effect of 
immobilization and recovery on IMCL and mitochondrial characteristics.   
IMCL number had a strong tendency to decrease (p = 0.053, Fig 7A), though only during 
recovery, and IMCL size was unaffected by either immobilization or recovery (Fig 7B). 
However, there was a significant decrease in IMCL area density in the SS region as a result of 
immobilization (p = 0.009, Fig 7C), which remained reduced upon recovery. The lower IMCL 
area density following recovery was due to a decrease in IMCL number. As IMCL metabolism is 
closely linked to mitochondrial content and function, the proximity of IMCL to mitochondria 
was assessed during immobilization and recovery. There was no change in IMCL-mitochondrial 
proximity in the SS region (Fig 7D).  
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Figure 7: IMCL size (A), number (B), and area density (C) in the subsarcolemmal (SS) region of 
skeletal muscle before (D0) and after (D14) of immobilization and after recovery (D28). The box 
plot shows the median (line) and mean (+), with the box representing the IQR and the whiskers 
representing the maximum and minimum values. Data are reported for 12 participants. Analysis 
by 2-way ANOVA. * denotes a significant difference from D0, p = 0.009. AD: area density; 
IMCL: intramyocellular lipid.  
 
In the IMF region there was no effect of immobilization or recovery on IMCL 
characteristics in the peripheral IMF region (Fig 8A,C,E, respectively). Alternatively, IMCL size 
increased significantly in the central IMF (p = 0.007; Fig 8B) region as a result of 
immobilization. IMCL size returned to baseline upon the reintroduction of mobility. 
Interestingly, the number of IMCL in the central IMF region did not change as a result of 
immobilization, but there was a significant decrease in the number of IMCL during recovery (p = 
0.032, Fig 8D). Therefore, the IMCL area density tended to increase in the central IMF (p = 
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0.077; Fig 8F) region with immobilization, and tended to decrease back to near pre-
immobilization levels upon recovery.  
 
  
Figure 8: IMCL size (A,B), number (C,D), and area density (E,F) in the peripheral and central 
intermyofibrillar (IMF) region, respectively, of skeletal muscle before (D0) and after (D14) 
immobilization and after recovery (D28). The box plot shows the median (line) and mean (+), 
with the box representing the IQR and the whiskers representing the maximum and minimum 
values. Data are reported for 12 participants. Analysis by 2-way ANOVA. * denotes a significant 
increase from D0, p = 0.007. # denotes a significant decrease from D0, p = 0.032. IMCL: 
intramyocellular lipid. 
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Figure 9: Representative images of IMCL before (D0; A) and after (D14; B) immobilization and 
after recovery (D28; C) taken at 5800x. The images show the decrease in IMCL in the SS region 
and the increase in IMCL in the central IMF during immobilization and the decrease in the 
number of SS IMCL and the decrease in IMCL in the central IMF during recovery. IMCL are 
denoted by white arrows.  
 
Similar to the IMCL characteristics, there was no change in mitochondrial-IMCL 
proximity in the peripheral IMF region during immobilization or recovery (Fig 10A). In the 
central IMF region, despite there being an increase in IMCL area density with immobilization, 
there was no change in IMCL-mitochondrial apposition; however, there was a significant 
decrease in the proximity of IMCL to mitochondria in the central IMF region during recovery (p 
= 0.002; Fig 10B).  
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Figure 10: Proximity of IMCL and mitochondrial in the peripheral (A) and central (B) 
intermyofibrillar (IMF) region, represented as a percentage of IMCL that are touching at least 1 
mitochondrion in skeletal muscle before (D0) and after (D14) immobilization and after recovery 
(D28). The box plot shows the median (line) and mean (+), with the box representing the IQR 
and the whiskers representing the maximum and minimum values. Data are reported for 12 
participants. Analysis by 2-way ANOVA. * denotes a significant decrease from D0, p = 0.002. 
IMCL: intramyocellular lipid. Mito: mitochondria. 
 
 As with IMCL, immobilization and recovery altered mitochondrial area density. There 
was a significant decrease in mitochondrial area density in the SS region from pre-
immobilization to recovery (p = 0.002; Fig 11A), yet pairwise analyses revealed only a trend 
towards a decrease during immobilization (p = 0.087). Similar to the IMCL, there was no effect 
of immobilization or recovery on mitochondrial area density in the peripheral IMF region (Fig 
11B). While there was no effect of immobilization on mitochondrial area density in the central 
IMF region, mitochondrial area density decreased in the central IMF (p = 0.001; Fig 11C) region 
upon recovery. Therefore, the change in mitochondrial area density induced by immobilization 
only became significant after immobilization was completed.  
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Figure 11: Mitochondrial area density in the subsarcolemmal (SS) region (A) and the peripheral 
(B), and central (C) intermyofibrillar (IMF) region of skeletal muscle before (D0) and after 
(D14) immobilization and after recovery (D28). The box plot shows the median (line) and mean 
(+), with the box representing the IQR and the whiskers representing the maximum and 
minimum values. Data are reported for 12 participants. Analysis by 2-way ANOVA. * denotes a 
significant difference from D0, p = 0.002. # denotes a significant decrease from D0 and D14, p = 
0.001 Mito: mitochondria. AD: area density. 
 
 Finally, IMCL size, number, and area density of the entire fibre were determined 
regardless of its subcellular localization. IMCL number did not change during immobilization, 
but decreased during recovery (p = 0.039, Fig 12A). There was a trend towards an increase in 
IMCL size during immobilization and its return to baseline during recovery (p = 0.073, Fig 12B). 
Together, this equated to a trend towards increased IMCL area density during immobilization in 
the whole fibre and a return to baseline during recovery (p = 0.084, Fig 12C). 
 
 
Figure 12: IMCL number (A), size (B), and area density (C) in the entire muscle fiber before 
(D0) and after (D14) immobilization and after recovery (D28). The box plot shows the median 
(line) and mean (+), with the box representing the IQR and the whiskers representing the 
maximum and minimum values. Data are reported for 12 participants. Analysis by 2-way 
ANOVA. * denotes a significant decrease from D0, p = 0.039. IMCL: intramyocellular lipid. 
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4.3 IMCL, mitochondria, and insulin signalling protein expression 
 Next, we evaluated changes in the content of proteins related to IMCL metabolism, 
mitochondrial function, and insulin signalling. There was no effect of omega-3 FA 
supplementation on any of the proteins related to IMCL metabolism, mitochondrial function, or 
insulin signalling, thus graphs are shown to highlight the effect of immobilization and 
remobilization.  
 We measured PLIN2 and PLIN5 as markers of IMCL synthesis and breakdown, 
respectively. PLIN2 did not change during immobilization, but tended to increase upon recovery 
(p = 0.074, Fig 13A). PLIN5 content increased during immobilization and remained elevated 
during recovery (p = 0.011, Figure 13B).  
 
 
Figure 13: PLIN2 (A) and PLIN5 (B) protein expression of skeletal muscle after (D14) 
immobilization and after recovery (D28) relative to baseline (D0). Data are reported as the mean 
± SEM for 20 participants. Analysis by 2-way ANOVA. * denotes difference from D0, p = 
0.011.  
 
We measured AMPK and ACC as links between fat metabolism and insulin signalling149. 
Total AMPK content tended to increase (p = 0.071; Fig 14A) upon immobilization and stay 
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elevated during recovery, yet there was no change in phosphorylated AMPK (Fig 14B), which is 
its enzymatically active state. Interestingly, its downstream effector, ACC, had significantly 
increased phosphorylation during immobilization and returned to baseline during recovery (p = 
0.021, Fig 14C).  
 
 
Figure 14: Total (A) and phosphorylated (B) AMPK α and phosphorylated ACC (C) protein 
expression of skeletal muscle after (D14) immobilization and after recovery (D28) relative to 
baseline (D0). Data are reported as the mean ± SEM for 20 participants. Analysis by 2-way 
ANOVA. * denotes a significant increase from D0, p = 0.021. 
  
 We evaluated mitochondrial function by determining mitochondrial fission and fusion 
patterns. There was a trend towards a decrease in FIS1 content (p = 0.07, Fig 15A) during 
immobilization as well as a strong trend for OPA1 content to increase (p = 0.051, Fig 15B) in 
recovery. However, when expressed as a ratio of OPA1/FIS1, there was a significant increase (p 
= 0.035, Fig 15C) during recovery, suggesting a preference for mitochondrial fusion. Apoptotic-
related signalling was characterized by opposing apoptotic regulators. BCL2, an anti-apoptotic 
factor, significantly decreased upon immobilization and remained blunted during recovery (p = 
0.044, Fig 15C). Conversely, BAX, a pro-apoptotic factor, significantly increased during both 
immobilization and recovery (p = 0.001, Fig 15D). Despite the significant changes in BCL2 and 
BAX content, when expressed as a ratio of BCL2/BAX, there was no effect of immobilization or 
recovery (p = 0.50, Fig 15F). 
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Figure 15: FIS1 (A) and OPA1 (B) protein expression, OPA1/FIS1 ratio BCL2 (D) and BAX (E) 
protein expression, and BCL2/BAX ratio (F) of skeletal muscle after (D14) immobilization and 
after recovery (D28) relative to baseline (D0). Data are reported as the mean ± SEM for 20 
participants. Analysis by 2-way ANOVA. * denotes a significant increase from D0 and D14, p = 
0.035. ** denotes a difference from D0, p = 0.044. † denotes a difference from D0, p = 0.001. ‡ 
denotes a difference from D0 and D14, p = 0.001.  
 
 Disuse negatively impacts insulin sensitivity9,69,75 and IMCL is thought to play a role in 
the development of insulin resistance18,49, therefore several proteins along the insulin signal 
pathway were analyzed. There was no change in IRS1 during immobilization, but there was a 
significant increase during recovery (p = 0.039, Fig 16A). GLUT4 content did not change as a 
result of immobilization or recovery (Fig 16B). Total AKT content significantly increased with 
immobilization and tended to continue increasing during recovery (p = 0.002, Fig 16C), while 
phosphorylated AKT increased with immobilization and remained elevated during recovery (p = 
0.001, Fig 16D). The increase in AKT did not influence the total or phosphorylated content of its 
downstream substrate, AS160, during immobilization. However, there was a trend towards 
increased phosphorylated AS160 upon recovery (p = 0.075, Fig 16F). 
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Figure 16: IRS1 (A), GLUT4 (B), total (C) and phosphorylated (D) AKT, and total (E) and 
phosphorylated (F) AS160 protein expression of skeletal muscle after (D14) immobilization and 
after recovery (D28) relative to baseline (D0). Data are reported as the mean ± SEM for 20 
participants. Analysis by 2-way ANOVA. * denotes a significant increase from D0, p = 0.039. ** 
denotes a significant increase from D0, p = 0.002. # denotes a significant increase from D0, p = 
0.001. 
 
 
 
 53 
5.0 Discussion 
 This study aimed to assess changes in IMCL and mitochondrial characteristics during 
single leg immobilization and recovery and whether fish oil mitigated these effects. Based on the 
current literature, we believed that disuse would result in IMCL accumulation in the SS region 
and mitochondrial dysfunction, accompanied by decreased insulin signalling. These effects were 
expected to return to baseline during recovery. The key findings of this study are that: 1) 
immobilization increased IMCL content in the central IMF region and decreased content in the 
SS region, 2) mitochondrial content did not change during disuse, but decreased during recovery, 
and 3) immobilization increased total and phosphorylated AKT expression, which remained 
elevated in recovery. The disuse stimulus employed in this study was sufficient to influence 
muscle metabolism as evidenced by a decrease in muscle protein synthesis, muscle mass, and 
muscle function150. The novelty of this study is the examination of subcellular IMCL 
characteristics during disuse, not total content, as well as the continued assessment of all 
parameters following 2-weeks of recovery.  
 
Disuse influences IMCL and mitochondria storage characteristics 
IMCL area density significantly decreased in the SS region during immobilization and 
continued to decrease during recovery. While not significant, this change was mainly driven by a 
decrease in IMCL number (p = 0.053), not a decrease in IMCL size. These findings are contrary 
to our hypothesis that IMCL content would increase in the SS region during immobilization, 
antithetically to the effect of endurance training on SS IMCL content2,3. In fact, IMCL size and 
content in the SS region have been found to be negatively associated with IS2,4, thus our finding 
that SS IMCL content decreased with disuse is hard to reconcile as it suggests that disuse 
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induced a favourable effect on SS IMCL storage. However, since SS IMCL size has been related 
to IR4 and the decrease in SS IMCL content occurred without a change in IMCL size, it is likely 
that this was not a favourable change in IMCL storage, particularly considering that SS 
mitochondrial area density decreased during immobilization and remained lower during 
recovery. In T2D there is a 3-fold reduction in SS mitochondrial content and a 7-fold reduction 
in electron transport chain activity151, which have been suggested to negatively impact IS151,152. 
Insulin resistant individuals also have reduced rates of fat oxidation as evidenced by reduced 
carnitine palmitoyltransferase 1 content, reduced oxidative enzyme activity, and a higher 
respiratory quotient153,154. Yet, despite the reduced oxidative capacity found in this population by 
a companion study155, there was a decrease in SS IMCL content, which is hard to reconcile. 
However, decreased SS IMCL content is supported by the increase in ATGL seen during 
immobilization in the companion paper155. Several studies have found a negative association 
between SS IMCL content and IS in men2,36, but in women this relationship has not been 
observed3. The decrease in mitochondrial content suggests a negative impact of disuse in the SS 
region, but the decrease in IMCL content in the SS region, while unexpected, may indicate that 
SS IMCL storage is not related to IR in women.  
 Unlike the SS region, disuse and recovery did not affect peripheral IMF IMCL 
characteristics. Higher habitual physical activity has been shown to protect against the loss of 
peripheral lipid droplets30. As this was a young, recreationally active population, perhaps they 
were active enough to be protected against disuse-induced peripheral IMCL changes. However, 
IMCL area density in the central IMF region tended to increase with immobilization due to a 
significant increase in IMCL size. Increased IMCL size is related to IR, particularly in the central 
IMF4,30. Previous literature has found that IMCL content increases during immobilization10,86,90, 
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though the methods employed by these studies did not have the sensitivity to differentiate 
subcellular localization. Not all studies have found that IMCL content increases with disuse7, 
however this may be due to a shorter period of immobilization, 7 days compared to ≥ 14 days. 
Recently, it has been shown that the subcellular localization of IMCL is important to the 
functionality of IMCL metabolism as trained individuals and those with T2D preferentially store 
their IMCL in different locations4. If IMCL content had not been separated based on subcellular 
localization, the whole fibre analysis would have missed the decrease in IMCL area density in 
the SS region and the increase in IMCL area density in the central IMF region. These findings 
emphasize the need to use methods, such as electron microscopy, that can determine IMCL 
characteristics and storage location when evaluating the effects of an intervention on IMCL 
content.  
IMCL content is higher in the peripheral IMF region in athletes and is thought to 
represent a readily available fuel source to support ATP production due to the corresponding 
high mitochondrial content4. In untrained individuals IMCL content is greater in the central IMF 
region, which is in line with our results showing that with disuse IMCL accumulated exclusively 
in the central IMF and not the peripheral IMF. Furthermore, the increase in IMCL area density 
was due to increased IMCL size rather than number, and increased IMCL size in the IMF region 
has been negatively associated with IS, though this is seen only in type II fibres4. As such, fibre 
type has been implicated as an important factor when assessing IMCL quality4. Unfortunately, 
we were unable to determine fibre type in the current study to determine whether disuse had 
differing effects depending on fibre type. With recovery, the IMCL content returned to baseline 
levels in the central IMF region, due to a reduction in both IMCL size and number. 
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IMCL synthesis and breakdown are in part mediated by the PLINs. During disuse, IMCL 
area density in the SS region tended to decrease. At that time, there was a significant increase in 
PLIN5 content and no change in PLIN2 content. PLIN5 is thought to mediate IMCL-
mitochondrial apposition and provide a physical link between IMCL and fat oxidation26,33,156, 
thus the finding that PLIN5 and ATGL155 increased during immobilization may explain the 
decreased SS IMCL content seen in the current study. The decrease in SS IMCL and increased 
ATGL may indicate the IMCL were being reduced as the lipids were metabolized for energy, 
however a companion paper found a 20% reduction in ADP-stimulated respiration and 
significant reduction in COX proteins 155, suggesting that immobilization decreased the oxidative 
capacity of the muscle. However, this same companion paper found there was no change in lipid 
oxidation in the whole muscle, as evidenced by no change in β-hydroxyacyl dehydrogenase 
content or lipid-supported mitochondrial respiration155, suggesting that total lipid oxidation was 
unaffected by disuse. However, while total lipid oxidation may not have changed, the site of lipid 
utilization may have shifted as a decrease in IMCL in the SS region and an increase in IMCL in 
the IMF region would equate to a net zero change.  
Alternatively, in the absence of stimulus from exercise, PLIN5 can promote lipogenesis23. 
Therefore, without exercise, PLIN5 may be promoting lipogenesis rather than lipolysis, which 
would correspond with the increase in central IMF IMCL size seen in the current study. PLIN2 
favours a lipogenic phenotype23, yet when IMCL area density increases in the central IMF region 
during immobilization, there is no concurrent increase in PLIN2 content. Therefore, perhaps 
PLIN5 is mediating IMCL accumulation in the IMF regions. However, this contradicts its 
proposed activity in the SS region. Furthermore, during recovery there was an increase in PLIN2 
content at a point at which IMCL area density in the central IMF was decreasing, results which 
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are again hard to reconcile given the proposed role of PLIN2 to promote lipogenesis. During 
recovery, there was also a decrease in IMCL-mitochondrial apposition in the central IMF region 
despite elevated PLIN5 content. Acute and chronic exercise have been shown to increase IMCL-
mitochondrial apposition40,41, an effect thought to be mediated by PLIN533, yet apposition 
decreased in the IMF region during remobilization despite high PLIN5 content. Unfortunately, 
there was no evaluation on ATGL content during recovery to further evaluate IMCL metabolism 
during recovery155. Together, these findings raise several considerations that warrant further 
examination regarding the role of PLINs on IMCL content and apposition with mitochondria 
during and following disuse. However, it is important to note that while IMCL analyses were 
dependent on subcellular location, PLIN content was determined for the whole muscle 
homogenate. Similar to how the whole muscle analysis of IMCL content would have masked the 
decrease of IMCL in the SS region and the exclusive increase of IMCL in the central IMF, the 
analysis of PLIN content on whole muscle homogenate may be masking important subcellular 
influences of disuse on PLIN content/function. As such, separating the muscle into SS and IMF 
fractions may identify differential changes in PLINs induced by disuse that may align better with 
the changes seen in IMCL content and should be examined in future trials.  
 Several studies have shown that mitochondria area density decreases with disuse7,93,95,157 
and it significantly increases during recovery compared to immobilization, but does not return to 
pre-immobilization levels95. Disuse did not decrease mitochondrial area density in the IMF 
regions and it only tended to decrease in the SS region; however, similar to others109,157, our 
study showed that SS mitochondria are more susceptible to degradation with immobilization. 
Reduced mitochondrial content and function is also found in T2D and has been linked to the 
development of IR82,96. Nielsen et al. found a spatial relevance to mitochondrial degradation 
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where the further into the myocyte the less susceptible the mitochondria are to degradation with 
SS > periphery > central157. Meanwhile, our data suggests SS > central > periphery. Nielsen et 
al. estimated volume of mitochondria using point counting whereas we calculated area density 
by individually outlining the mitochondria. Furthermore, their electron microscopy images were 
also taken at 40,000X compared to ours at 5,800X. Our lower magnification would produce a 
larger image, which may better represent changes to large areas and could account for the 
discrepancy in IMF regional mitochondrial susceptibility.  
During recovery, mitochondrial content decreased significantly in the SS and central IMF 
regions. The effects of remobilization on mitochondrial content are controversial, with one study 
finding a partial recovery during remobilization95, but another finding no improvement158.The 
ubiquitin-protease system is not activated in recovery from immobilization as determined by the 
protein content of muscle RING-finger protein 1 (MURF) and muscle atrophy F-box protein 
(MAFBX)150, suggesting that this system is not contributing to the reduction in mitochondrial 
content that occurs following immobilization. However, it has been found in rats that following 8 
days of hindlimb unloading autophagy peaks at 6 days of recovery and is still significantly 
elevated at 10 days of recovery159. Based on these findings it has been suggested that 
remobilization increased autophagy to remove damaged organelles159. Damaged mitochondria 
produce more ROS, but a companion study found no changes in ROS production during 
immobilization, suggesting that mitochondrial damage was not occurring during immobilization. 
However, there was a significant increase in antioxidant protein content following 
immobilization155, which could mask an increase in ROS production induced by immobilization. 
Unfortunately, there was no evaluation of ROS production or antioxidant status during the 
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recovery period to support the hypothesis that autophagy/mitophagy may increase during 
recovery. 
 
 Disuse influences apoptotic signalling and mitochondrial dynamics 
BCL2 and BAX are anti- and pro-apoptotic factors, respectively, and their protein 
contents represents the balance of apoptotic signalling160. As expected and in agreement with 
other studies118,161, their expressions were differentially influenced by disuse with BCL2 
decreasing and BAX increasing during immobilization despite no change in the ratio of 
BCL2/BAX. During recovery, BCL2 remained in a depressed steady-state while BAX 
expression continued to increase, suggesting apoptosis-related signalling may still be elevated 
despite remobilization. The protein content of a downstream protease of BAX, caspase 9, is 
elevated in the tibialis anterior muscle of rats after 10 days of recovery from immobilization159, 
while caspase 9 protein content returns to pre-immobilization levels within 6 days of recovery in 
the gastrocnemius muscle159,162. Caspase-9 activity represents the activation of apoptosis that is 
often activated by immobilization159,162. In rats, gastrocnemius is a mixed type muscle while 
tibialis anterior has very few type I muscle fibres. These findings suggest that there may be a 
fibre type specific difference in proteolytic pathway activation during immobilization. 
Interestingly, Slimani et al. suggested that the increased apoptotic susceptibility of the tibialis 
anterior could be due to the fibre type shift induced by immobilization whereby there was an 
increase in type I fibres, which are most susceptible to proteolysis with unloading163. Type I 
fibres are the most prominent and largest fibres in female human vastus lateralis164, which may 
explain the increased BAX expression seen here during recovery. However, as BAX is early in 
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the apoptotic signalling pathway, it would be necessary to measure the proteins such as caspase-
3 to definitively identify changes in apoptotic activity111. 
Mitochondria are dynamic structures that constantly undergo fission and fusion to 
maintain health. During hindlimb suspension, animal studies have shown downregulation of 
fission and fusion proteins108,109 while others have shown increased fission protein content and 
decreased fusion protein content104,107. In humans, 10-days of bed rest did not change the content 
of fission or fusion proteins in older adults110. Mitochondrial remodeling has been shown to 
induce AMPK-FOXO3 signalling to induce atrophy, and FIS1 and DRP1 overexpression can 
exacerbate muscle atrophy. Despite no change in OPA1 during immobilization in the current 
study, there was a trend (p = 0.07) for FIS1 to decrease. A companion paper also found no 
significant changes in total content of mitochondrial fission and fusion during immobilization, as 
determined by MFN2 and DRP1 content, respectively, but there was a significant decrease in the 
ratio of MFN2/DRP1, suggesting a greater activation of fission155. We found no effect of 
immobilization on the ratio of OPA1/FIS1. Despite the tendency for FIS1 to decrease during 
immobilization, it was not powerful enough to change the balance between mitochondrial fusion 
to fission as determined by the ratio of OPA1/FIS1. Therefore the findings from our study and 
those of a companion paper both support no change in fission and fusion proteins during 
immobilization110; however, the ratio between fission and fusion may reveal more about 
mitochondrial dynamics. More research is needed to identify the cause of the discordance 
between the relative expression fission and fusion proteins with immobilization. While there was 
no evaluation of MFN2 or DRP1 during recovery, we found a strong trend (p = 0.051) for OPA1 
content to increase during recovery as mitochondrial content decreased along with a significant 
preference towards mitochondrial fusion as evidenced by an increase in OPA1/FIS1. To my 
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knowledge, no other studies have evaluated OPA1 content during recovery from immobilization, 
but IS has a positive relationship with a mitochondrial fusion phenotype, which would agree with 
the increase in OPA1 expression during recovery seen here165. 
 
Disuse does not change or increases insulin signalling proteins in young women 
 Immobilization induces insulin resistance9,69,75, thus we hypothesized that there would be 
a decrease in insulin signalling pathway proteins. Despite the acceptance that disuse induces 
insulin resistance6,9,69,75, there has been almost no examination of the effect of disuse on the 
insulin receptor or its substrate IRS1. In the current study, we found no effect of disuse on IRS1; 
however, IRS1 increased during recovery. Previous studies have shown that unloading can 
induce increased phosphorylation of the serine residues on IRS1 in as little as two weeks in 
mice166,167. Serine phosphorylation increases over time concurrently with IRS1 degradation166. 
When IRS1 is serine phosphorylated instead of tyrosine phosphorylated, it is unable to interact 
with the insulin receptor168. IRS1-serine phosphorylation is also seen in insulin resistance169. 
Therefore, even though we found no change in IRS1 content during disuse, there may be a 
change in its activity levels and this should be explored in future studies.  
 One of the outcomes of insulin signalling is to increase GLUT4 translocation to the 
membrane. GLUT4 translocation is inhibited by AS160 and this inhibition can be removed by 
phosphorylating and thereby inhibiting AS160, which can be done by either AMPK or AKT. Yet 
despite both AKT and AMPK increasing or tending to increase, respectively, during 
immobilization, there was no increase in AS160 phosphorylation during immobilization; 
however, it did tend to increase upon recovery. When AS160 phosphorylation increased in 
recovery, so did IRS1 content, which may represent an increase in insulin signalling during 
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recovery. These findings suggest that there may be changes in signalling with disuse that mediate 
or interrupt AS160 phosphorylation. This is corroborated by Biensø et al. who also found no 
increase in AS160 content with 12-days of bed rest85; however, they did not explore its 
expression during recovery. GLUT4, whose translocation is controlled by AS160, also did not 
change with immobilization. GLUT4 has been shown to increase167, decrease85, and not 
change170 with hindlimb unloading, 12-days of bed rest, and 9-days of bed rest, respectively. 
During recovery when AS160 phosphorylation increased, GLUT4 content did not increase, but it 
was measured in whole muscle homogenate, and so no comment can be made on whether disuse 
or recovery influenced its translocation to the sarcolemma.  
 One of the proteins responsible for GLUT4 subcellular location is AMPK. AMPK 
activity is regulated and increased by phosphorylation and allosterically via AMP149. An energy 
imbalance in ATP/AMP is a potent activator of AMPK and has been seen in disuse118. We found 
that total AMPK tended to increase and remain elevated during recovery, but there was no 
concomitant increase in AMPK phosphorylation status at any time point. Due to the dramatic 
decrease in mitochondrial content during immobilization (SS) and recovery (SS & IMF), an 
imbalance of ATP/AMP is likely occurring. Yet, while some studies support increased AMPK 
expression during disuse107,171, there are also studies that show no change in total or 
phosphorylated AMPK170,172,173. Unfortunately, there have been a variety of immobilization 
conditions tested in both human and animal trials, and as such the source of the discrepancy is 
unclear. ACC is a downstream effector of AMPK so its increased phosphorylation, indicating 
lower activity, during immobilization is in line with our AMPK findings. However, ACC 
phosphorylation status returned to pre-immobilization levels during recovery despite total 
AMPK expression tending to remain elevated. When active (dephosphorylated), ACC promotes 
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fatty acid synthesis, which is favourable for PLIN2 expression23. PLIN2 content did not change 
with immobilization, in agreement with previous findings86, but tended to increase with 
recovery. The dephosphorylation of ACC during recovery despite no IMCL accumulation also 
suggests a high IMCL turnover, in agreement with the increase of PLIN2 and PLIN5 content 
seen during recovery.  
Another prominent regulator of AS160 phosphorylation and therefore GLUT4 
translocation is AKT. In the current study total and phosphorylated AKT expression increased 
with immobilization and remained elevated during recovery. The effect of disuse on AKT 
content appears to be time-dependent with Liu et al. finding that AKT phosphorylation decreased 
during the first 3 – 7 days of hindlimb unloading in males rats, yet it was elevated above pre-
immobilization levels at day 14, though not significantly108. Therefore, it is necessary to factor in 
the length of disuse when evaluating AKT status across studies. However, the findings from the 
current study conflict with those from many studies in humans85,170,174 and animals167,173,175 that 
have found that total and/or phosphorylated AKT decreases in response to a variety of 
immobilization protocols. AKT is a potent regulator of the mammalian target of rapamycin 
(mTOR), which initiates protein synthesis176–178. Both AKT and mTOR respond to feeding and 
in the current study the muscle biopsies were taken in the fasted state179. As such, it would be 
important to also evaluate the effect of immobilization on AKT and mTOR in the fed state in 
order identify changes to protein content once the proteins have been properly activated179. 
Regardless, an increase in AKT is unexpected; however, an increase in AKT has been seen in 
animal studies during immobilization108,118,180. While a previous study found that both mTOR 
and AKT increased during disuse, the increase in mTOR was found to be independent of AKT, 
indicating that the activation of AKT will not reverse muscle atrophy during disuse11.  
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Furthermore, a companion study found no change in mTOR gene expression despite a decrease 
in muscle protein synthesis and a loss in muscle mass150. The finding that mTOR did not change 
despite an increase in AKT content is supportive of a disassociation between AKT and mTOR 
during disuse.  
Interestingly, two of the three studies that showed an increase in AKT during disuse were 
done in females rodents118,180, while only one of six studies that exhibited a decrease in AKT was 
done in female rodents167. Estrogen has been shown to increase GLUT4 content and IS in male 
mice and is believed to protect premenopausal women against T2D45. Ovariectomy reduces 
whole body insulin-stimulated glucose uptake and decreases GLUT4 content in skeletal 
muscle181,182. Disuse is known to induce IR9,69,75, yet in the current study we did not find an 
effect of disuse on insulin signalling in skeletal muscle, the largest storage depot for glucose 
within the body74. To my knowledge, the only study that compared the effect of disuse on IS in 
men and women was a step reduction study where the evaluation of IS was collapsed because the 
population was older men and post-menopausal women183. As such, it is possible that young 
women are protected against the deleterious effects of disuse on insulin sensitivity due to 
estrogen. Importantly, the aforementioned human studies that found no increase in total or 
phosphorylated AKT during recovery were done exclusively in men and none of them examined 
IRS1 content or AS160 phosphorylation status174,175,184. Thus, estrogen may prevent the 
deleterious effects of disuse by preventing declines in insulin signaling during disuse and 
perhaps even speeding recovery and warrants further examination.  
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Omega-3 FA supplementation did not influence IMCL or mitochondrial storage characteristics, 
apoptosis-related signalling, or insulin signalling 
 Omega-3 supplementation has been found to increase muscle protein synthesis12,13 and 
can attenuate the loss of muscle mass during disuse150. Given that muscle mass is the largest 
storage depot for glucose, we hypothesized that omega-3 FA supplementation would attenuate 
declines in insulin signalling, which may be mediated by its effect on IMCL storage 
characteristics. Contrary to our hypothesis, there was no effect of omega-3 FA supplementation 
on IMCL storage characteristics or insulin signalling. The effectiveness of omega-3 FA 
supplements has been shown to be reliant on several factors including the dose administered, the 
length of the intervention, and habitual omega-3 FA consumption. Furthermore, whether the 
supplement actually contains the appropriate level of EPA and DHA and participant compliance 
will also influence the effectiveness of omega-3 FA supplementation. In the current trial 
supplementation adherence was confirmed by determining levels of EPA and DHA in the 
phospholipids of red blood cells, which were found to increase ~3-fold in the first 2-weeks of 
supplementation, prior to immobilization, and remained constant throughout the duration of the 
study150. EPA has been found to rapidly incorporate itself into the membranes of red blood cells 
and have been suggested to mask non-adherence185. These findings also support that the omega-3 
FA supplement contained the appropriate levels of EPA and DHA. Despite no effects of omega-
3 FA on any of the outcomes measured in the current trial, two companion papers found 
significant effects of omega-3 FA supplementation suggesting that the dose and length of 
supplementation was sufficient to induce metabolic effects within skeletal muscle. As well, the 
dose and length of intervention employed by the current trial was longer than other studies that 
have shown that omega-3 FA supplementation during disuse can attenuate declines in muscle 
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protein synthesis150,186, suggesting that the lack of effect of omega-3 FA supplementation on 
IMCL metabolism and insulin signalling is a valid finding. The habitual diet of the individuals 
can influence the effectiveness of a supplementation trial.  High habitual omega-3 FA intake or 
the supplementation with omega-3 FA could prevent an effect of supplementation as participants 
may have already been consuming adequate amounts of omega-3 FA. In the current trial 
participants were excluded from the trial if they had supplemented with omega-3 FA within the 
past 6 months. Furthermore, the fact that our two companion studies did find an effect of 
supplementation on outcomes related to muscle protein synthesis and mitochondrial function 
suggest that our participants benefited from omega-3 FA supplementation. Together, these 
findings suggest that the lack of effect of omega-3 FA supplementation seen in the current trial 
was due to the fact that omega-3 FA do not influence IMCL, not due to an inadequate 
supplementation regime.  
There are conflicting reports of the effects of omega-3 FA supplementation in humans125, 
however many long term supplementation trials have found that omega-3 FA increases mRNA 
expression across a host of metabolic avenues, including the insulin signalling pathway and 
IMCL synthesis 122,123,137. These findings suggest that omega-3 FA influence gene expression, 
which is supported by findings in the liver and brain where omega-3 FA increased the gene 
expression and regulated the activity of gene transcription factors187,188. However, increased gene 
expression does not always correspond with increased protein content137, which may explain 
why we did not see an effect of omega-3 FA supplementation in the current trial. 
Omega-3 FA also incorporate themselves into membranes where they influence the 
activity of proteins134. Many of the proteins evaluated in the current study, particularly all of the 
insulin signalling pathway proteins, are cytosolic and their protein content, not activity, was 
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measured. In a companion study150, omega-3 FA supplementation increased muscle protein 
synthesis and blunted the immobilization-induced increase in ubiquitin ligase gene expression. 
Similarly, in another companion paper, omega-3 FA supplementation preserved the protein 
content of all the COX proteins and preserved mitochondrial sensitivity to ADP155. Given that 
these analyses were conducted in the same group of participants, these findings may suggest a 
preference for EPA and DHA to regulate oxidative metabolism and muscle protein synthesis 
over insulin signalling and IMCL metabolism. This is supported by multiple studies involving 
omega-3 FA supplementation for 6 months that failed to see a change in whole body insulin 
signalling in healthy populations125.  
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6.0 Future Directions and Conclusions 
 In this study there were several findings that varied from previous literature as well as 
findings contrary to our hypotheses that warrant further investigation. SS IMCL area density 
decreased during immobilization and it, along with IMCL size, continued to decrease during 
recovery. SS IMCL accumulation is associated with IR2,4. Endurance training induces a shift in 
IMCL storage from the SS region to the IMF region2,3, a shift that has been found to be 
associated with improved IS in men2, but not women3. Since disuse is the antithesis to endurance 
training and induces insulin resistance6,9,75, it was believed that IMCL would accumulate in the 
SS region as this is negatively associated with IR4. Instead, SS IMCL decreased during disuse, a 
change that is thought to have a positive impact on IS4. Women are inherently more insulin 
sensitive than men189,190 and in the current study AKT content increased in our female 
population, whereas in previous studies conducted in men AKT decreased with disuse85,170,174. 
Perhaps estrogen mitigated the negative effects of disuse on IMCL metabolism and insulin 
signalling, with particular emphasis on the AKT pathway. Interestingly, high intensity interval 
training has been shown to improve IS in men, but not women191,192. Furthermore, it has been 
suggested that the insulin-sensitizing effect of exercise in women may be blunted191. Therefore, 
perhaps the effect of disuse on insulin signalling and insulin sensitivity is also blunted in women 
and requires further examination.  
The current study undertook a careful examination of the effects of disuse on IMCL and 
mitochondrial storage characteristics in multiple subcellular locations within the myocyte. IMCL 
and mitochondrial content decreased, as did their apposition, during recovery in the IMF region. 
There was no change in PLIN2 content during disuse, but IMF IMCL content increased as did 
PLIN5 content. As PLIN5 promotes lipolysis and PLIN2 promotes lipid accumulation, these 
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findings seem contradictory. Unfortunately, while we were able to characterize the effects of 
disuse on IMCL and mitochondria within different myocyte regions, we were only able to 
determine whole muscle PLIN content. As the subcellular regions of IMCL storage had opposing 
reactions to disuse, assessment of PLIN proteins in subfractionated muscle homogenate 
(myofibrillar vs. sarcolemmal) may have provided insight into how IMCL content was decreased 
in the SS region and increased in the IMF region.  
Often, studies that evaluate the effects of disuse do not continue to study the effect of 
disuse when mobility is resumed7,8,86,155. Our analyses show that many of the effects of disuse 
become apparent during recovery from immobilization. Indeed, mitochondrial content did not 
decrease during immobilization, but did decrease during recovery in the SS and central IMF 
regions. Furthermore, IRS1 did not change during immobilization but increased during recovery. 
Finally, AKT, P-AKT, and PLIN5 increased and BCL2 decreased during immobilization and 
remained higher/lower during recovery. As such, these findings highlight the prolonged effect of 
disuse on muscle metabolism and the importance of continuing to study the effects of disuse past 
the return of mobility. 
 One defining aspect of this study was its population. We chose to examine the effects of 
disuse in women because previous research in older adults found that women may experience 
greater rates of muscle mass decline during disuse, and thus potentially a greater induction of 
insulin resistance, as compared with men. However, the findings of the current study suggest that 
women are protected against disuse-induced impairments in insulin signalling as there was no 
decrease in any insulin signalling proteins with disuse and AKT actually increased. Given that 
most studies that have been conducted looking at the effects of disuse on muscle metabolism 
have included men, and not women, as research participants it is difficult to reconcile whether 
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our results are contrary to what has been previously found or if they are due to the inclusion of 
women as participants. Regardless, our findings highlight the importance of including women as 
research participants. A follow up study that compares the effects of disuse on IMCL storage 
characteristics, fat metabolism and insulin signalling in both sexes is needed to determine 
whether sex influences the effect of disuse on these outcomes.  
In conclusion, two weeks of unilateral limb immobilization in young, healthy females 
induced central IMF IMCL accumulation and maintained the protein content of the insulin 
signalling pathway. Two weeks of recovery was sufficient to normalize IMCL accumulation and 
ACC phosphorylation status, but FIS1 content remained lower and BAX content remained 
elevated, suggesting that two weeks of recovery is insufficient to completely reverse the effects 
of immobilization. Given that women have a lower risk of developing type 2 diabetes than 
men181, despite greater adiposity, an effect thought to be mediated by estrogen, it is hypothesized 
that estrogen may be mediating the effect of disuse on insulin signalling proteins in young 
women.  
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Appendix 
Supplementary data examining the effect of 4-weeks of omega-3 supplementation on IMCL and 
mitochondrial characteristics. 
 
 
 
 
Supplementary figure 1 IMCL size (A), number (B), and area density (C) in the subsarcolemmal 
(SS) region of skeletal muscle before supplementation (Pre) and before immobilization (D0) 
after 4-weeks of supplementation. The box plot shows the median (line) and mean (+), with the 
box representing the IQR and the whiskers representing the maximum and minimum values. 
Data are 13 participants. Analysis by 2-way ANOVA. Clear: Placebo. Grey: Fish Oil. Pre: 
Before supplementation. D0: Before immobilization, after 4-weeks of supplementation.AD: area 
density; IMCL: intramyocellular lipid. 
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Supplementary figure 2 IMCL size (A,B), number (D,E), and area density (G,H) in the 
peripheral, central, and total intermyofibrillar (IMF) regions, respectively, of skeletal muscle 
after 4-weeks of supplementation. The box plot shows the median (line) and mean (+), with the 
box representing the IQR and the whiskers representing the maximum and minimum values. 
Data are 13 participants. Analysis by 2-way ANOVA. Clear: Placebo. Grey: Fish Oil. Pre: 
Before supplementation. D0: Before immobilization, after 4-weeks of supplementation. AD: area 
density; IMCL: intramyocellular lipid.  
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Supplementary figure 3 Proximity of IMCL and mitochondrial in the subsarcolemmal (SS) 
region (A) and the peripheral (B), and central (C) intermyofibrillar (IMF) region, represented as 
a percentage of IMCL that are touching at least 1 mitochondrion in skeletal muscle after 4-weeks 
of supplementation. The box plot shows the median (line) and mean (+), with the box 
representing the IQR and the whiskers representing the maximum and minimum values. Data are 
13 participants. Analysis by 2-way ANOVA. Clear: Placebo. Grey: Fish Oil. Pre: Before 
supplementation. D0: Before immobilization, after 4-weeks of supplementation. IMCL: 
intramyocellular lipid; Mito: mitochondria.  
 
 
 
 
 
Supplementary figure 4 Mitochondrial area density in the subsarcolemmal (SS) region (A) and 
the peripheral (B), and central (C) intermyofibrillar (IMF) region of skeletal muscle after 4-
weeks of supplementation. The box plot shows the median (line) and mean (+), with the box 
representing the IQR and the whiskers representing the maximum and minimum values. Data are 
13 participants. Analysis by 2-way ANOVA. Clear: Placebo. Grey: Fish Oil. Pre: Before 
supplementation. D0: Before immobilization, after 4-weeks of supplementation. IMCL: 
intramyocellular lipid; Mito: mitochondria.  
 
